Pending

Multisite reliability and repeatability of an advanced brain MRI protocol.
Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis.
Manic episode in patient with bipolar disorder and recent multiple sclerosis diagnosis: A case report.
Rehabilitation Improves Mitochondrial Energetics in Progressive Multiple Sclerosis: The Significant Role of Robot-Assisted Gait Training and of the Personalized Intensity.
Revisiting remyelination: Towards a consensus on the regeneration of CNS myelin.
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study.
COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis.
A single, clinically relevant dose of the GABAB agonist baclofen impairs visuomotor learning.
Course of neuropsychological impairment during Natalizumab associated progressive multifocal leukoencephalopathy.
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome.
[The multiple sclerosis functional composite correlates with the sociomedical recommendation of earning capacity of rehabilitants with Multiple Sclerosis].
Contralateral Strength Training as Preparation for Direct Strength Training in a Patient With Unilateral Foot-Drop Because of Multiple Sclerosis: A Case Report.
A recursive framework for predicting the time-course of drug sensitivity.
Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis.
Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada.
Walking in multiple sclerosis improves with tDCS: a randomized, double-blind, sham-controlled study.
Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis.
Magnetic resonance spectroscopy of the normal appearing grey matter in the posterior cingulate gyrus in the prognosis and monitoring of disease activity in MS patients treated with interferon-β in a 3-year follow-up.
Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.
Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?
Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring.
Multiple doses of cell therapy and neurorehabilitation in amyotrophic lateral sclerosis: A case report.
B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic – when immunosuppression meets infection?
Artifactual hypoglycemia in a patient with systemic sclerosis.
Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis
High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice.
The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models.
The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials.
TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.
[Treatment of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis during the COVID-19 Pandemic].
Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis.
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.
Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review.
Monitoring the Redox Status in Multiple Sclerosis.
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
Aminopiridines in the treatment of multiple sclerosis and other neurological disorders.
Vaccine-associated measles in a patient treated with natalizumab: a case report.
PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139.
Comprehension of confidence intervals in audio-visual patient information materials for people with multiple sclerosis (COCO-MS): A web-based randomised controlled, parallel group trial.
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis.
PSYCHIATRIC DISORDERS IN THE COURSE OF MULTIPLE SCLEROSIS.
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Assessment of Pediatric Optic Neuritis Visual Acuity Outcomes at 6 Months.
Secondary progressive multiple sclerosis – from neuropathology to definition and effective treatment.
Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation.
Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.
Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
Minocycline for the Management of Multiple Sclerosis: Repositioning Potential, Opportunities, and Challenges.
Multiple sclerosis: NICE recommends treatment for secondary progressive MS.
Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide.
Upfront Combination Therapy With Rituximab and Mycophenolate Mofetil for Progressive Systemic Sclerosis.
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported Outcomes.
PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-κB.
The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View.
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis.
Re-Examining the Role of TNF in MS Pathogenesis and Therapy.
Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.
The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls.
A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective.
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS)
Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS)
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
The effect of exercise on high-level mobility in individuals with neurodegenerative disease: a systematic literature review.
Effectiveness of expiratory muscle strength training on expiratory strength, pulmonary function and cough in the adult population: a systematic review.
Delivering Transcranial Direct Current Stimulation Away From Clinic: Remotely Supervised tDCS.
A Descriptive Cross-Sectional Study of Manipulative Dexterity on Different Subtypes of Multiple Sclerosis.
Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with Escherichia coli.
Focus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment.
Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis.
Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue.
Botulinum toxin type A for hand tremor: a meta-analysis of randomised controlled trials.
Tenofovir as a treatment option for multiple sclerosis.
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?
Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study.
Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks.
Impact of disease-modifying drugs on severity of COVID-19 infection in multiple sclerosis patients.
Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy.
Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis.
Qigong for Multiple Sclerosis: A Feasibility Study
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.
Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Neural implant for the treatment of multiple sclerosis.
The Effects of Omega-3 Supplementation on the Expanded Disability Status Scale and Inflammatory Cytokines in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis.
Effect of task-oriented circuit training on motor and cognitive performance in patients with multiple sclerosis: A single-blinded randomized controlled trial.
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals.
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod.
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis.
Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma.
Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain-derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity.
Recent developments in MOG-IgG associated neurological disorders.
Relapsing and progressive MS: the sex-specific perspective.
Paramagnetic Rims in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Quantitative Susceptibility Mapping Study with 3-T MRI.
Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles.

How Much Vitamin D is Too Much? A Case Report and Review of the Literature.
RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers.
The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis.
Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
The relationship between dimensions of mental health and alexithymia in multiple sclerosis patients.
Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.
Treatment response score to glatiramer acetate or interferon beta-1a.
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab.
Internuclear Ophthalmoplegia as the First Manifestation of Pediatric-Onset Multiple Sclerosis and Concurrent Lyme Disease.
A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis.
Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
Epley Manoeuvre in Participants With Multiple Sclerosis Diagnosed From Benign Paroxysmal Positional Vertigo
TRPMS to Improve Mobility and Depression in Multiple Sclerosis
Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.
Mediating Role of Resilience on Quality of Life in Individuals With Multiple Sclerosis: A Structural Equation Modeling Approach.
Practical Sleep Information for People With Multiple Sclerosis.
Stem Cell Therapy for Neurogenic Bladder Dysfunction in Rodent Models: A Systematic Review.
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis.
The right therapeutic method of ozone therapy used to treat multiple sclerosis patients.
Prevalence And Impact Of Myofascial Pain Syndrome In Relapsing-Remitting Multiple Sclerosis And The Effects Of Local Anesthetic Injections For Short-Term Treatment.
Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease?
Oleanolic Acid Acetate Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis in Mice by Regulating Toll-Like Receptor 2 Signaling.
CADASIL vs. Multiple Sclerosis: Is It Misdiagnosis or Concomitant? A Case Series.
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study.
The DQB1*03:02 Genotype and Treatment for Pain in People With and Without Multiple Sclerosis.
Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients.
Comparative Analysis of Roseoloviruses in Humans, Pigs, Mice, and Other Species.
Acceptability and outcomes of an individualized exergaming telePT program for veterans with multiple sclerosis: a pilot study.
Multiple Sclerosis: Impact on Oral Hygiene, Dysphagia, and Quality of Life.
Efficacy of an Internet-Based Program to Promote Physical Activity and Exercise after Inpatient Rehabilitation in Persons with Multiple Sclerosis: A Randomized, Single-Blind, Controlled Study.
Gut microorganisms act together to exacerbate inflammation in spinal cords.
Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysis.
Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa.
Case Report: Adult Still’s Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient.
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis.
Smell as a clinical-marker for functional limitations in multiple sclerosis: A pilot study.
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment.
Focus on Chinese herbal medicine therapy for multiple sclerosis by dialectical treatment.
Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis.
Renal tumors in tuberous sclerosis complex.
MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.
Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment.
A bibliometric evaluation of the top 100 cited natalizumab articles.
A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT.
Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
HFP (High-Fiber Supplement) in MS (Multiple Sclerosis)
Graph Theoretic Analysis of Brain Connectomics in Multiple Sclerosis: Reliability and Relationship with Cognition.
Application of Cannabinoids in Neurosciences: Considerations and Implications.
Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis.
B cells reappear less mature and more activated after their anti-CD20-mediated depletion in multiple sclerosis.
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings.
Editorial: Expanding the indications for autologous stem cell transplantation: do we need a new approach to supportive care for patients with multiple sclerosis?
Occupational performance in multiple sclerosis and its relationship with quality of life and fatigue.
[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors].
What is the role of axonal ion channels in multiple sclerosis?
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.
Clinical Applications of Bee Venom Acupoint Injection.
Chronic Facial Pain: Trigeminal Neuralgia, Persistent Idiopathic Facial Pain, and Myofascial Pain Syndrome-An Evidence-Based Narrative Review and Etiological Hypothesis.
Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature.
Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination.
SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression.
Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a.
The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
The Effect of a Polysaccharide-Based Multinutrient Dietary Supplementation Regimen on Infections and Immune Functioning in Multiple Sclerosis.
Remaining At Home With Severe Disability.
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis.
Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275.
The role of microRNAs in multiple sclerosis.
Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects
Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data.
Multiple Sclerosis Attack Case Presenting with Pseudo-Vestibular Neuritis.
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies.
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis.
Nursing interventions in autologous stem cell transplantation for autoimmune diseases.
Neuromyelitis optica spectrum disorder: an overview.
Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice.
Psychosocial adjustment to multiple sclerosis diagnosis: A meta-review of systematic reviews.
Intravascular iliac artery lithotripsy to enable transfemoral thoracic endovascular aortic repair.
Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.
Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis.
Biomarkers of inflammation and epithelial barrier function in multiple sclerosis.
COVID-19 in multiple sclerosis patients and risk factors for severe infection.
Blockade of Kv1.3 potassium channel inhibits CD8+ T cell-mediated neuroinflammation via PD-1/Blimp-1 signaling.
Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis.
Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
Fasciola hepatica-Derived Molecules as Regulators of the Host Immune Response.
Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report.
Teriflunomide-exposed pregnancies in a French cohort of patients with multiple sclerosis.
Epilepsy in Children with Tuberous Sclerosis Complex: A Prospective Observational Study in Bangladesh.
[Mechanisms underlying remyelination with special focus on demyelination models of multiple sclerosis].
Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis.
Central pain syndromes.
Ketogenic diet and Neuroinflammation.
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

Wireless, Implantable Tibial Nerve Stimulator System for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.
Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis.
Multiple sclerosis and COVID-19: how many are at risk?
Genetic factors for susceptibility to and manifestations of neuromyelitis optica.
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis.
COVID-19 in people with multiple sclerosis: A global data sharing initiative.
MS, pregnancy and COVID-19.
Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS) as neurodegenerative diseases and their treatments: A review.
Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration.
Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis.
Impaired Verb-Related Morphosyntactic Production in Multiple Sclerosis: Evidence From Greek.
Comorbidity in Multiple Sclerosis.
Cystic echinococcosis causing thrombosis of the inferior vena cava in a patient with multiple sclerosis treated with alemtuzumab.
TRPV4-Mediated Regulation of the Blood Brain Barrier Is Abolished During Inflammation.
Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis.
In Vivo Proton Exchange Rate (kex ) MRI for the Characterization of Multiple Sclerosis Lesions in Patients.
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis.
High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.
The effect of yoga on the quality of life and fatigue in patients with multiple sclerosis: A systematic review and meta-analysis of randomized clinical trials.
Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
Keeping standards of multiple sclerosis care through the COVID-19 pandemic.
Employment status of people with multiple sclerosis in relation to 10-year changes in functioning and perceived impact of the disease.
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017.
Impact of Exercise on Immunometabolism in Multiple Sclerosis.
Home Based Tele-exercise for People With Chronic Neurological Impairments: COVID and Beyond
Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
Alemtuzumab-associated diffuse alveolar damage – a case report.
Implications of Vitamin D in Multiple Sclerosis and Other Neurodegenerative Processes: Bibliometric Analysis and Systematic Review.
The current status and challenges in multiple sclerosis management in the Philippines.
High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue
Self-administered Hyperinsufflation Chest Mobilization Randomized Study on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit
Case of Susac’s syndrome initially diagnosed as multiple sclerosis.
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis.
Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS.
The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
In vivo imaging of chronic active lesions in multiple sclerosis.
Analysis of defective pathways and drug repositioning in Multiple Sclerosis via machine learning approaches.
Recommendations on vitamin D needs in multiple sclerosis from the MS Society of Canada.
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
Case Report: Confirmation by Metagenomic Sequencing of Visceral Leishmaniasis in an Immunosuppressed Returned Traveler.
Renal Manifestations of Tuberous Sclerosis Complex.
Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis.
Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis.
Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.
αB-crystallin as a promising target in pathological conditions – A review.
Changes in structural and functional connectivity during two years of fingolimod therapy for multiple sclerosis.
Isolated opsoclonus heralding neuromyelitis optica spectrum disorder.
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain.
Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI.
Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Modeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every-4-Week Dosing to Extended-Interval Dosing.
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
A systematic review of oral health in people with multiple sclerosis.
Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran.
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY).
The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis.
Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
haMSter: a Novel Smartphone Communication Tool for People With MS
Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients.
Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis.
Formal and informal care received by middle-aged and older adults with chronic conditions in Canada: CLSA data.
[Robotic mechanotherapy in patients with multiple sclerosis with impaired walking function].
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Pediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment.
Physical activity, sitting time and exercise types, and associations with symptoms in Australian people with multiple sclerosis.
Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis.
Inflammatory colitis associated with Teriflunomide.
Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.
My MS Toolkit + Coaching: A Guided Web-based Symptom Self-Management Program for People With MS
Benefits and harms of medical cannabis: a scoping review of systematic reviews.
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
Interleukin-17 and ischemic stroke.
Brain activity changes following neuroproprioceptive “facilitation, inhibition” physiotherapy in multiple sclerosis: a parallel group randomized comparison of two approaches.
An adult case of parainfectious optic neuritis associated with genital herpes simplex virus type 2 infection.
Racial Disparities in Medicaid Home and Community-Based Service Utilization among White, Black, and Hispanic Adults with Multiple Sclerosis: Implications of State Policy.
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.
Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study.
[Comparison of the clinical benefits of second-line drugs modifying the course of multiple sclerosis].
[Neuropathic pain: Pharmacotherapy].
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis.
Enhancing quality of life in progressive multiple sclerosis with powered robotic exoskeleton.
Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
Hepatitis B vaccination and central demyelination – History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
Motivational interviewing to promote health outcomes and behaviour change in multiple sclerosis: a systematic review.
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].
Health service utilization in immigrants with multiple sclerosis.
Cuprizone-induced demyelination in mouse hippocampus is alleviated by ketogenic diet.
Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.
Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement.

Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1.
Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model.
Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in France.
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients.
Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis.
Sensor-based technology for upper limb rehabilitation in subjects with multiple sclerosis: A randomized controlled trial.
Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke.
Imaging Butyrylcholinesterase in Multiple Sclerosis.
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
Intermittent caloric restriction with a modified fasting-mimicking diet ameliorates autoimmunity and promotes recovery in a mouse model of multiple sclerosis.
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany.
Dicrocoelium Ova Can Block the Induction Phase of Experimental Autoimmune Encephalomyelitis.
Proximal Resistance Training for People With Multiple Sclerosis
Effect of Pilates Training in Patients With Multiple Sclerosis
Tools for comprehensive evaluation of sexual function in patients with multiple sclerosis.
Creatine and multiple sclerosis.
CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis.
Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL/6 Mouse Model of Demyelination.
[Engaging clinicians to identify and prioritize disinvestment opportunities in the treatment of neurodegenerative diseases: a qualitative study.]
The Changes in 1H-MRS Metabolites in Cuprizone-Induced Model of Multiple Sclerosis: Effects of Prior Psychological Stress.
Speech metrics, general disability, brain imaging and quality of life in MS.
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials.
Unraveling B-lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets.
Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis.
Lymphomatosis cerebri masquerading as the Marburg variant of multiple sclerosis.
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.
Aerobic Exercises for Multiple Sclerosis
The IL-12 cytokine family in cardiovascular diseases.
Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis.
Time-Based Prospective Memory Is Associated with Functional Performance in Persons with MS.
Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Feasibility of Real Time Internet-Based Teleconsultation in Patients With Multiple Sclerosis: Interventional Pilot Study.
Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases.
Morpholino Analogues of Fingolimod as Novel and Selective S1P1 Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis.
The BAFF / APRIL system as therapeutic target in multiple sclerosis.
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
Design, synthesis, and anti-neuroinflammatory activity of amidecontaining dithiolethiones.
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.
Autoantigen Tetramer Silences Autoreactive B Cell Populations.
A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose-Possible Predictors of Cardiac Outcomes.
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Effect of Cervical Mobilization on Tonus and Plantar Pressure Distribution in Multiple Sclerosis
Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders.
A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis
Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report.
Multiple sclerosis, human herpesvirus 4 and thyroid collision tumor: A case report.
Immune reconstitution, glomerulonephritis, and successful treatment with rituximab.
Differential diagnosis in acute inflammatory myelitis.
A systematic review and meta-analysis of randomized controlled trials to evaluating the trend of cytokines to vitamin A supplementation in autoimmune diseases.
Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.
Discerning novel drug targets for treating Mycobacterium avium ss. paratuberculosis-associated autoimmune disorders: an in silico approach.
Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis.
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Rituximab and glatiramer-acetate in secondary-progressive multiple sclerosis: A randomized-clinical trial.
Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod.
Immunohistochemical Analysis of Protective Effects of Maternal Fingolimod on the Placenta and Fetal Lung and Brain in Chorioamnionitis-Induced Preterm Birth Rat Model.
A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocyte transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotype.
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.
Autologous Hematopoietic Stem Cell Transplantation in Neurological Disorders: Current Approach and Future Directions.
Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis.
Introduction: Druggable Lipid Signaling Pathways.
A Phase 1 Single and Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 in Healthy Volunteers and Multiple Sclerosis Subjects
Shikonin ameliorates experimental autoimmune encephalomyelitis (EAE) via immunomodulatory, anti-apoptotic and antioxidative activity.
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.
CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders.
Persons with Multiple Sclerosis Exhibit Strength Asymmetries in both Upper and Lower Extremities.
High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients.
Urinary tract infection in patients with multiple sclerosis: An overview.
Aerobic Exercise for Remyelination in Multiple Sclerosis
Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination.
An international discrete choice experiment assessing patients’ preferences for disease-modifying therapy attributes in multiple sclerosis.
Health Related Quality of Life in Patients with Onco-hematological Diseases.
The co-occurrence of multiple sclerosis and Evans syndrome: A case report.
Mycobacterium avium complex infection in a patient with systemic sclerosis- associated interstitial lung disease: A case report.
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study.
Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon.
Using normalisation process theory to understand barriers and facilitators to implementing mindfulness-based stress reduction for people with multiple sclerosis.
FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia.
The Association between Body Mass Index and Leisure-Time Physical Activity in Adults with Multiple Sclerosis.
Association Between System Usage Pattern and Impact of Web-Based Telerehabilitation in Patients with Multiple Sclerosis.
Health Behaviors, Wellness, and Multiple Sclerosis Amid COVID-19.
Effects of immunomodulatory drug Fingolimod (FTY720) on Chlamydia dissemination and pathogenesis.
Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population.
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis.
The anticonvulsive Phenhydan® suppresses extrinsic cell death.
Decrease in Secondary Neck Vessels in Multiple Sclerosis: A 5-year Longitudinal Magnetic Resonance Angiography Study.
The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis
Are information provision interventions effective for people with multiple sclerosis? A Cochrane Review summary with commentary.
Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study.

Intermittent catheterization and urinary tract infection in multiple sclerosis patients.
Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients.
Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study.
A case report with tuberculous meningitis during fingolimod treatment.
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS.
The Energetic Origin of Neurodegeneration in MS
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
Therapeutic potential of neuromodulation for demyelinating diseases.
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab.
The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards.
Acquired factor VIII inhibitor in a patient with multiple sclerosis treated with interferon β-1a.
Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis.
A comparative study of the effects of yoga and clinical Pilates training on walking, cognition, respiratory functions, and quality of life in persons with multiple sclerosis: A quasi-experimental study.
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register.
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms.
Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis.
Menopause and multiple sclerosis: Influence on prognosis and role of disease-modifying drugs and hormonal replacement therapy.
A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: Protocol for a randomized controlled trial.
Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders.
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis.
[Radiologically isolated syndrome: prognosis and predictors of conversion to multiple sclerosis].
[Myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis].
[Registry-based comparison of multiple sclerosis epidemiology trend data in 1999 and 2019: the case of Yaroslavl].
[The use of music therapy in the treatment of adverse effects in patients with multiple sclerosis treated with alemtuzumab].
[Experience in designing an electronic multiple sclerosis registry].
[Effect of different groups of first line DMT on endothelial damage in multiple sclerosis].
[Multifocal inflammatory levamisole-induced leukoencephalopathy].
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
FTY720 in CNS injuries: Molecular Mechanisms and Therapeutic Potential.
The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study.
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy).
Relapsing Demyelinating Syndromes in Children: A Practical Review of Neuroradiological Mimics.
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).
Myasthenia Gravis and Physical Exercise: A Novel Paradigm.
Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab-A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry.
Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis: A Study Protocol for a Randomized Clinical Trial.
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study.
Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.
Fatal COVID-19 in an MS patient on natalizumab: A case report.
Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis.
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
The Effect of High Tone Power Therapy on Fatigue and Functional Outcomes in Multiple Sclerosis
Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
Effect of CoDuSe Balance Training and Step Square Exercises on Risk of Fall in Multiple Sclerosis
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Personalized Yoga Therapy for Multiple Sclerosis: Effect on Symptom Management and Quality of Life.
Biotransformation of cladribine by a nanostabilized extremophilic biocatalyst.
Multiple sclerosis in a young woman with sickle cell disease.
Predictive probability of success using surrogate endpoints.
Percutaneous Venous Angioplasty in Patients with Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency.
Self-efficacy and walking performance across the lifespan among adults with multiple sclerosis.
Relationship Between Exercise Duration in Multimodal Telerehabilitation and Quality of Sleep in Patients with Multiple Sclerosis.
Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Reorganization of multiple sclerosis health care system in Clinical Centre of Montenegro during the COVID-19 pandemic.
Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis.
Functional electrical stimulation for foot drop in people with multiple sclerosis: The relevance and importance of addressing quality of movement.
Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients.
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID.
Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report.
iTBS Study for Depression in Patients With Multiple Sclerosis
Impaired micronutrients and prealbumin in patients with established and very early systemic sclerosis.
CLINICAL course of acute disseminated encephalomyelitis in adults from Rio de Janeiro: Retrospective study of 23 cases and literature review.
Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy.
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.
The Use of Electrochemical Voltammetric Techniques and High-Pressure Liquid Chromatography to Evaluate Conjugation Efficiency of Multiple Sclerosis Peptide-Carrier Conjugates.
Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review.
Do modern therapies change natural history of Neuromyelitis optica?
Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cord.
High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study.
CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis.
Self-Powered Direct Muscle Stimulation Using a Triboelectric Nanogenerator (TENG) Integrated with a Flexible Multiple-Channel Intramuscular Electrode.
Helicobacter pylori infection: Beyond gastric manifestations.
Protective Effects of Leukadherin1 in a Rat Model of Targeted Experimental Autoimmune Encephalomyelitis (EAE): Possible Role of P47phox and MDA Downregulation.
Mirabegron versus solifenacin in multiple sclerosis patients with overactive bladder symptoms: a prospective comparative non-randomized study.
Effects of dietary restriction on gut microbiota and CNS autoimmunity.
Multiple sclerosis in Pakistan: Current status and future perspective.
Instrumented Version of the Modified Dynamic Gait Index in Patients With Neurologic Disorders.
Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
Beyond barrier functions: Roles of pericytes in homeostasis and regulation of neuroinflammation.
Glomerulonephritis With Positive Anti-Glomerular Basement Membrane Antibodies Following Alemtuzumab Treatment.
Turning Toward Monitoring of Gaze Stability Exercises: The Utility of Wearable Sensors.
Long-term prognostic value of longitudinal measurements of blood neurofilament levels.
Accurate Diagnosis of Multiple Sclerosis Using Hybrid Positron Emission Tomography/Magnetic Resonance (PET/MR)
Physiotherapy assessment of individuals with multiple sclerosis prior to a group intervention – A qualitative observational and interview study.
Targeted delivery for neurodegenerative disorders using gene therapy vectors: Gen next therapeutic goals.
Rates, patterns, and correlates of fitness tracker use among older adults with multiple sclerosis.
Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells.
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.
Dietary education programs for adults with neurological diseases: a scoping review protocol.
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
StatPearls
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studies.
IL-23 and dendritic cells: What are the roles of their mutual attachment in immune response and immunotherapy?

Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.
A Systematic Review of Cerebral Functional Near-Infrared Spectroscopy in Chronic Neurological Diseases-Actual Applications and Future Perspectives.
Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders.
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Patient-reported financial toxicity in multiple sclerosis: Predictors and association with care non-adherence.
A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases.
Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis.
Physical activity participation according to the pyramidal, sensory, and cerebellar functional systems in multiple sclerosis.
Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: Resolution with Everolimus Treatment.
Effect of Eccentric Strength Training on Elbow Flexor Spasticity and Muscle Weakness in People With Multiple Sclerosis: Proof-of-Concept Single-System Case Series.
Trunk and foot acceleration variability during walking relates to fall history and clinical disability in persons with multiple sclerosis.
Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target.
Secular trends in disease modifying treatment and expenditure in multiple sclerosis: A longitudinal population study in the north of Ireland.
[Variability of the Mitochondrial Genome and Development of the Primary Progressing form of Multiple Sclerosis].
Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review.
Current perspectives on co-morbid depression and multiple sclerosis.
Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta.
Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.
Erratum to “Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm” [Neurologia. 2020;35(6):357-362].
The Role of TH17 Cells in Multiple Sclerosis: Therapeutic Implications.
Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes.
Lymphocyte recovery after fingolimod discontinuation in patients with MS.
REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person ‘Managing Fatigue’ interventions on the impact of fatigue among persons with multiple sclerosis.
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach.
An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases.
Olive Leaf Polyphenols Attenuate the Clinical Course of Experimental Autoimmune Encephalomyelitis and Provide Neuroprotection by Reducing Oxidative Stress, Regulating Microglia and SIRT1, and Preserving Myelin Integrity.
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients.
Applications of Head-Mounted Displays for Virtual Reality in Adult Physical Rehabilitation: A Scoping Review.
Branch retinal vein occlusion associated with fingolimod treatment for multiple sclerosis.
Assessing upper limb function in Multiple Sclerosis by an engineered glove.
Preventing Job Loss Using Acceptance and Commitment Therapy in Vocational Rehabilitation
Opposing and potentially antagonistic effects of BMP and TGF-β in multiple sclerosis: The “Yin and Yang” of neuro-immune Signaling.
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
Focus on Data: Statistical Significance, Effect Size and the Accumulation of Evidence Achieved by Combining Study Results Through Meta-analysis.
Opicinumab: is it a potential treatment for multiple sclerosis?
Commentary on: “Calling Out MS Fatigue: Feasibility and Preliminary Effects of a Pilot Randomized Telephone-Delivered Exercise Intervention for Multiple Sclerosis Fatigue”.
Vaccines for measles, mumps, rubella, and varicella in children.
Systematic review of prediction models in relapsing remitting multiple sclerosis.
Lipid-specific IgMs induce antiviral responses in the CNS: implications for progressive multifocal leukoencephalopathy in multiple sclerosis.
Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis.
Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands.
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review.
Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP-100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial.
The nature of anger in people with multiple sclerosis: a qualitative study.
Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis.
Idebenone does not inhibit disability progression in primary progressive MS.
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020.
The effect of a telerehabilitation virtual reality intervention on functional upper limb activities in people with multiple sclerosis: a study protocol for the TEAMS pilot randomized controlled trial.
Timing of Communication Device Introduction Defined by ALSFRS-R Score in Patients with Amyotrophic Lateral Sclerosis.
Hyperglucosylated adhesin-derived peptides as antigenic probes in multiple sclerosis: Structure optimization and immunological evaluation.
Evaluation of serum human epididymis protein 4 in patients with relapsing-remitting multiple sclerosis.
Feasibility and acceptability of a single-session, videoconference-delivered group intervention for pain in multiple sclerosis.
Impact of obstructive sleep apnoea on cognitive function in multiple sclerosis: A longitudinal study.
Physical and functional aspects of persons with multiple sclerosis practicing Tai-Geiko: randomized trial.
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives.
Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States.
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
Neuroinflammation at single cell level: What is new?
Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study.
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
IFI35 as a biomolecular marker of neuroinflammation and treatment response in multiple sclerosis.
Serum neurofilament-light concentration and real-world outcome in MS.
Enhanced Recruitment During Executive Control Processing in Cognitively Preserved Patients With Pediatric-Onset MS.
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
Bcl6 modulates innate immunity by controlling macrophage activity and plays critical role in experimental autoimmune encephalomyelitis.
First-ever treatment in multiple sclerosis.
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis.
Eculizumab in the treatment of neuromyelitis optica spectrum disorder.
Multiple sclerosis management during the COVID-19 pandemic.
Bu-Shen-Yi-Sui Capsule, an Herbal Medicine Formula, Promotes Remyelination by Modulating the Molecular Signals via Exosomes in Mice with Experimental Autoimmune Encephalomyelitis.
Effect of natalizumab treatment on metalloproteinases and their inhibitors in a mouse model of multiple sclerosis.
Varicella Zoster immunity loss in multiple sclerosis patient treated with ocrelizumab.
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.
Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?
Neuroimmunologic disorders in pregnancy.
Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone.
Effects of MS disease-modifying therapies on responses to vaccinations: A review.
Distinctive sphingolipid patterns in chronic multiple sclerosis lesions.
Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years.
Network-based modeling of drug effects on disease module in systemic sclerosis.
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
Efficacy and safety of fampridine for walking disability in multiple sclerosis.
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient.
Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios.
The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis.
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.
Oxidative/Nitroxidative Stress and Multiple Sclerosis.
Serious safety events in rituximab-treated multiple sclerosis and related disorders.
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.
Conscientiousness and deterioration in employment status in multiple sclerosis over 3 years.
Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Audiovestibular symptoms in patients with multiple sclerosis: A correlation between self-reported symptomatology and MRI findings to monitor disease progression.
Auricular acupuncture for the treatment of nonepileptic seizures: A pilot study.
A Case of Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids.

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis.
Randomized feasibility trial to assess tolerance and clinical effects of lithium in progressive multiple sclerosis.
Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis.
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease.
Lipoic acid modulates inflammatory responses of monocytes and monocyte-derived macrophages from healthy and relapsing-remitting multiple sclerosis subjects.
Accuracy of FRAX® in People With Multiple Sclerosis.
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
Dissecting task-specific plasticity capacity in patients with multiple sclerosis with transcranial magnetic stimulation.
MOG Antibody Associated Disease: How it Differs From and Resembles Other Neuroinflammatory Disorders.
Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment.
Sensorized Tip for Monitoring People with Multiple Sclerosis that Require Assistive Devices for Walking.
Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
iPS-Derived Early Oligodendrocyte Progenitor Cells from SPMS Patients Reveal Deficient In Vitro Cell Migration Stimulation.
[Treatment and Management of Spasticity].
Real-World Treatment Patterns of Disease Modifying Therapy (DMT) for Patients with Relapse-Remitting Multiple Sclerosis and Patient Satisfaction with Therapy: Results of the Non-Interventional SKARLET Study in Slovakia.
Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis.
Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain.
Critical factors influencing the decision to enroll in a physical activity intervention among a predominant group of adults with spinal cord injury: a grounded theory study.
Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis.
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study.
Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model.
Application of stem cell transplantation in autoimmune diseases.
The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis.
Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial.
CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome.
Long-term drug treatment in multiple sclerosis: safety success and concerns.
Induction of a higher-ordered architecture in glatiramer acetate improves its biological efficiency in an animal model of multiple sclerosis.
Conventional Vestibular Training Versus Virtual Reality- Based Vestibular in Multiple Sclerosis
Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodulation
Imaging correlates of visual function in multiple sclerosis.
Effectiveness of Physical Therapy Interventions in Reducing Fear of Falling among Individuals with Neurological Diseases: A Systematic Review and Meta-analysis.
Conduction Delays in the Visual Pathways of Progressive Multiple Sclerosis Patients Covary with Brain Structure.
An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy.
N-Glycan Branching Decouples B Cell Innate and Adaptive Immunity to Control Inflammatory Demyelination.
SPINCOMS Biomarker Study
Examining the Efficacy of Non-invasive Neuromodulation in Reducing Symptoms of Multiple Sclerosis – a Pilot Study
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration.
Epidemiology of neurologic disease in pregnancy.
Protein kinase inhibitors for Amyotrophic Lateral Sclerosis therapy.
Actigraph-Measured Movement Correlates of Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Young People with Tuberous Sclerosis Complex (TSC) with and without Intellectual Disability and Autism Spectrum Disorder (ASD).
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis.
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.
Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis.
Enabling More Accessible MS Rehabilitation Training Using Virtual Reality.
The Effect of Coffee and Caffeine Consumption on Patients with Multiple Sclerosis-Related Fatigue.
The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-β therapy in the 3-year follow-up: a preliminary report.
Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Understanding Pediatric Neuroimmune Disorder Conflicts: A Neuroradiologic Approach in the Molecular Era.
Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.
Cognitive rehabilitation for attention and memory in people with multiple sclerosis: a randomized controlled trial (CRAMMS).
Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis.
The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation-Evidence from In Vivo Studies.
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Lipid Profile Alterations during Fingolimod Treatment in Multiple Sclerosis Patients.
Clinical assessment, management and rehabilitation of walking impairment in MS: An Expert Review.
Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microglia.
Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America.
Validation of the functional assessment of chronic illness therapy – General treatment satisfaction (FACIT-TS-G) in multiple sclerosis.
Long-term outcome in multiple sclerosis patients treated with fingolimod.
Does Siponimod Exert Direct Effects in the Central Nervous System?
Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study.
Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018.
Recent trends in the development of peptide and protein-based hydrogel therapeutics for the healing of CNS injury.
Parity and disability progression in relapsing-remitting multiple sclerosis.
[Erratum to: Ocrelizumab for treatment of multiple sclerosis].
Sexual functioning in patients with multiple sclerosis and its association with social support and self-esteem.
Statins in COVID-19: is there any foundation?
Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke.
Clinical effectiveness of reduced fingolimod dose in relapsing remitting multiple sclerosis-a Portuguese cohort.
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis.
Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis.
Tyrosine Kinase Receptors Axl and MerTK Mediate the Beneficial Effect of Electroacupuncture in a Cuprizone-Induced Demyelinating Model.
Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.
Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research.
Therapy-resistant dysphagia successfully treated using pharyngeal electrical stimulation in a patient with the pharyngeal-cervical-brachial variant of the Guillain-Barré syndrome.
Gestational vitamin D and offspring risk of multiple sclerosis: a systematic review and meta-analysis.
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study.
Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord.
Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article.
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.
The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
Gait asymmetry, and bilateral coordination of gait during a six-minute walk test in persons with multiple sclerosis.
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
Lesion stage-dependent causes for impaired remyelination in MS.
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.
Multiple sclerosis and related disorders: Short report peripheral vascular events in a real-world cohort of multiple sclerosis patients using Fingolimod.
Effects of co-administration of rapamycin and evening primrose / hemp seed oil supplement on immunologic factors and cells membrane fatty acids of experimental autoimmune encephalomyelitis.
Training the brain: could it improve multiple sclerosis treatment?
Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment.
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis.
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
The effect of novel simple saffron syrup on fatigue reduction in patients with multiple sclerosis.

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
Under and Over Rehabilitation Study
Switching to fingolimod in PREFERMS: Effect of treatment history and naïvety on clinical, MRI and treatment satisfaction outcomes✰.
Utilization of High-Cost Interventions for Targeted Clinical Conditions During the Early Stages of ACO Development in a Commercially Insured Population.
Recent advances of long noncoding RNAs involved in the development of multiple sclerosis.
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations.
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic.
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT.
Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.
Backward walking sensitively detects fallers in persons with multiple sclerosis.
Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion.
Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disorders.
A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.
[Prevalence and impact of comorbidities in patients with multiple sclerosis].
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.
Remyelination in multiple sclerosis: from basic science to clinical translation.
Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.
Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis
Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study.
Dietary responses to a multiple sclerosis diagnosis: a qualitative study.
Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis.
Dimethyl fumarate suppresses metastasis and growth of melanoma cells by inhibiting the nuclear translocation of NF-κB.
Dabigatran Suppresses PAR-1/SphK/S1P Activation of Astrocytes in Experimental Autoimmune Encephalomyelitis Model.
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
The importance of physical activity to preserve hippocampal volume in people with multiple sclerosis: a structural MRI study.
Biomarkers as an opportunity to stratify for outcome in systemic sclerosis.
Dimethyl fumarate alters intracellular Ca2+ handling in immune cells by redox-mediated pleiotropic effects.
Evaluation of Myelin Radiotracers in the Lysolecithin Rat Model of Focal Demyelination: Beware of Pitfalls!
Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Volumetric imaging of myelin in vivo using 3D inversion recovery-prepared ultrashort echo time cones magnetic resonance imaging.
The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice.
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
Engineering biomaterial microenvironments to promote myelination in the central nervous system.
[Medical cannabinoids and their indications in chronic pain].
A neuropsychologically-based intervention with increased follow-up support for employed women with multiple sclerosis: a pilot randomized controlled trial.
Diroximel fumarate in the treatment of multiple sclerosis.
Multiple sclerosis and COVID-19.
Eriodictyol suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis.
Trends in hospital readmissions in Multiple Sclerosis patients between 2009 and 2015.
Treatment of Multiple Sclerosis: A Review.
Candidate Gene Association Analysis of Multiple Sclerosis in the Jordanian Arab Population: A Case-Control Study.
Effect of combined exercise training on pentraxins and pro- inflammatory cytokines in people with multiple sclerosis as a function of disability status.
Attitudes of patients with relapsing-remitting form of multiple sclerosis using disease-modifying drugs in Montenegro regarding COVID-19 pandemic.
Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis.
Immunologic Effects of Vitamin D on Human Health and Disease.
Cerebellar Intermittent Theta-Burst Stimulation Combined with Vestibular Rehabilitation Improves Gait and Balance in Patients with Multiple Sclerosis: a Preliminary Double-Blind Randomized Controlled Trial.
Chemical genetic analysis of FTY720- and Ca2+ -sensitive mutants reveals a functional connection between FTY720 and membrane trafficking.
A concerns report survey of physical activity support needs of people with moderate-to-severe MS disability and family caregivers.
Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases.
Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases.
Gene therapy, a novel therapeutic tool for neurological disorders: Current progress, challenges and future prospective.
Serum neurofilament light as a biomarker in progressive multiple sclerosis.
Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.
Endoplasmic reticulum stress in the dorsal root ganglia regulates large-conductance potassium channels and contributes to pain in a model of multiple sclerosis.
[Anti-NMDAR encephalitis associated with relapsing optic neuritis].
The role of the brain in the treatment of multiple sclerosis as a connectomopathy.
A Digital Patient Portal for Patients With Multiple Sclerosis.
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
The “Treatise on the spleen and stomach” (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature – A hypothesis based on the analysis of clinical presentation and herbal medicine.
Short-term lung function changes and predictors of progressive systemic sclerosis-related interstitial lung disease.
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan.
High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study.
Use of a symptom-based questionnaire to screen for the presence of significant voiding dysfunction in patients with multiple sclerosis and lower urinary tract symptoms: a pilot study.
Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other’s course?
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
What’s in a name? That which we call Multiple Sclerosis Fatigue.
Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.
Exploiting relationships between outcomes in Bayesian multivariate network meta-analysis with an application to relapsing-remitting multiple sclerosis.
Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
[COMPLEXITIES IN THE DIFFERENTIAL DIAGNOSIS OF MULTIPLE SCLEROSIS AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (CLINICAL CASE)].
Capitalising on the opinions of persons with multiple sclerosis to inform the main trial – participant opinions from participation in a feasibility study, a qualitative extension study.
Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis.
Immunological effects of vitamin D and their relations to autoimmunity.
Whole-body reversible neuropathic pain associated with right parieto-temporal operculum single inflammatory lesion in a patient with multiple sclerosis: A case report.
Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report.
Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H2S-Producing Enzymes in Multiple Sclerosis.
Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis.
Current Perspectives on Exercise Training in the Management of Multiple Sclerosis.
Inhibition of RhoA/ROCK pathway in the early stage of hypoxia ameliorates depression in mice via protecting myelin sheath.
Development of autoimmune thyroid disease in multiple sclerosis patients post-alemtuzumab improves treatment response.
Sleep quality can influence the outcome of patients with multiple sclerosis.
Effects of virtual reality associated with serious games for upper limb rehabilitation inpatients with multiple sclerosis: randomized controlled trial.
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
Repetitive percutaneous radiofrequency thermocoagulation for persistent idiopathic facial pain and central neuropathic pain attributed to multiple sclerosis-a retrospective monocentric analysis.
Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation.
Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience.
COVID-19 in multiple sclerosis: The Dutch experience.
Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study.
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Pathogenic T cell cytokines in multiple sclerosis.
Phosphodiesterase Type 4 Inhibition in CNS Diseases.
The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)2D3.
Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression.

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
Longitudinal Intravital Microscopy Reveals Axon Degeneration Concomitant With Inflammatory Cell Infiltration in an LPC Model of Demyelination.
Can We Improve the Monitoring of People With Multiple Sclerosis Using Simple Tools, Data Sharing, and Patient Engagement?
Sex effects across the lifespan in women with multiple sclerosis.
Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic.
Sphenopalatine Ganglion Block: Treatment of Migraine and Trigeminal Neuralgia Associated With Multiple Sclerosis.
Cannabidiol for Viral Diseases: Hype or Hope?
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Medical cannabis: What practitioners need to know.
Ultra-high field 7 T imaging in multiple sclerosis.
Biotin Interference in Susceptible CanAg Ca242 Immunoassays and Elimination Method.
Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion.
Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis.
Posterior Reversible Encephalopathy Syndrome, Multiple Sclerosis and interferon therapy: Association, co-incidence or convoluted interplay?
The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides.
Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosis.
Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources.
A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis.
GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
Physical and Cognitive Functions, Physical Activity, and Sedentary Behavior in Older Adults With Multiple Sclerosis.
Views of healthcare professionals on training for and delivery of a fatigue self-management program for persons with multiple sclerosis.
Barriers and solutions to participation in exercise for moderately disabled people with multiple sclerosis not currently exercising: a consensus development study using nominal group technique.
Psychometric properties of the Arabic Activities-specific Balance Confidence scale in people with multiple sclerosis: Reliability, validity, and minimal detectable change.
Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question.
Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod.
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
Efficiency Model of Cladribine Tablets Versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple Sclerosis.
Diroximel fumarate to treat multiple sclerosis.
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy.
Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in Taiwan.
Targeting P2X4 and P2X7 receptors in multiple sclerosis.
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
Alterations in circulating T cell functional subpopulations in interferon-beta treated multiple sclerosis patients: A pilot study.
Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis.
Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
StatPearls
Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration.
StatPearls
A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran.
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases.
Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma.
Occupational therapy interventions for multiple sclerosis: A scoping review.
Non-invasive Transcranial Electrical Stimulation in MS
AI in Radiology: Where are we today in Multiple Sclerosis Imaging?
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Relapses in multiple sclerosis reported by patients versus physicians – Insights from a large observational study.
Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.
Effectiveness of blood flow-restricted slow walking on mobility in severe multiple sclerosis: a pilot randomized trial.
Dimethyl fumarate protects cardiomyocytes against oxygen-glucose deprivation/reperfusion (OGD/R)-induced inflammatory response and damages via inhibition of Egr-1.
The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis.
The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients.
Assessment of Language Disorders in Multiple Sclerosis Patients
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.
Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Effects and mechanisms of differently cued and non-cued motor imagery in people with multiple sclerosis: A randomised controlled trial.
Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study.
Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis.
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.
Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis.
Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version.
A proof-of-concept study of extracting patient histories for rare/intractable diseases from social media.
Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
Increased mental health care use by mothers of children with multiple sclerosis.
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Expert opinion on the use of cladribine tablets in clinical practice.
A case of Disseminated Herpes Zoster in a patient with Multiple Sclerosis on Glatiramer acetate.
Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices.
Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis.
Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis.
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score.
Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.
The effect of ellagic acid on spinal cord and sciatica function in a mice model of multiple sclerosis.
Real-World Goal Setting and Use of Outcome Measures According to the International Classification of Functioning, Disability and Health: A European Survey of Physical Therapy Practice in Multiple Sclerosis.
Design, synthesis, and biological evaluation of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation-Use of a conformation-based hypothesis to facilitate compound design.
Cannabinoids in multiple sclerosis: A neurophysiological analysis.
What does first-line therapy mean for paediatric multiple sclerosis in the current era?
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study.
G-POEM may be an optional treatment for refractory gastroparesis in systemic sclerosis.
N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
Long term results of augmentation cystoplasty and urinary diversion in multiple sclerosis.
Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.
Motor Learning in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.
Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton’s Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials.
Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
[Conotation of ancient “stroke” and Qianyin Yaofang Xiaoxuming Decoction treating cerebral infarction and cerebral hemorrhage].
[Experience of treating facial neuritis, unexplained limb weakness, cervical spondylosis, acute myelitis, acute radiculitis, Guillain Barre syndrome, multiple sclerosis, myasthenia gravis, motor neuron disease, dermatomyositis with Xiaoxuming Decoction].
Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?
MSCOVID19: Using social media to achieve rapid dissemination of health information.
Monomethyl fumarate has better gastrointestinal tolerability profile compared with dimethyl fumarate.
Dissolving microneedles for the delivery of peptides – towards tolerance-inducing vaccines.
A feasibility trial of an internet-delivered psychological intervention to manage mental health and functional outcomes in neurological disorders.
Multiple sclerosis with intractable vomiting and atypical area postrema lesion.
Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.
Relapsing paralytic ileus in multiple sclerosis requiring surgery: a video case report.
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients.

A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis.
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity.
Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy.
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.
Factors Associated With Medication Use Among Individuals Living With Multiple Sclerosis.
Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran.
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile.
Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis.
CSF chitinase 3-like-1 association with disability of primary progressive MS.
Data Collection in Multiple Sclerosis: The MSDS Approach.
Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis.
Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months.
The influence of trait mindfulness on depression in multiple sclerosis: potential implications for treatment.
Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice.
Dysregulation of NF-κB-Associated lncRNAs in Multiple Sclerosis Patients.
Time matters: Early-phase multiple sclerosis is accompanied by considerable impairments across multiple domains.
Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis.
Epigenetic insights into multiple sclerosis disease progression.
Can t2 blackout effect be A marker of iron accumulation in brains of multiple sclerosis patients ?: A qualitative study.
Discovery and Function of B Cell IgD Low (BDL) B Cells in Immune Tolerance.
Optic neuropathy: A 15-year retrospective observational study.
Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.
Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies.
Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.
Test-Retest Reliability and Response Stability of Gaze Stabilization, Postural Sway, and Dynamic Balance Tests in Persons with Multiple Sclerosis and Controls.
Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis.
A Case of Drug-Induced Liver Injury Secondary to Natalizumab.
Vaccination-associated acute disseminated encephalomyelitis.
Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients.
Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases.
Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.
Secretion of proteins and antibody fragments from transiently transfected endothelial progenitor cells.
Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.
Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning.
Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls.
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study.
Challenges in systemic sclerosis trial design.
Exoskeleton-assisted Gait Training in Persons With Multiple Sclerosis: A Single-Group Pilot Study.
Effectiveness and Adverse Events of Use of Natalizumab in a Brazilian Cohort of Patients With Multiple Sclerosis.
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors.
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report.
The Effect of Transcranial Direct Current Stimulation on Chronic Neuropathic Pain in Patients with Multiple Sclerosis: Randomized Controlled Trial.
Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction.
Primaquine elicits Foxp3+ regulatory T cells with a superior ability to limit CNS autoimmune inflammation.
Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis.
Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders.
Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.
Theta burst stimulation ameliorates symptoms of experimental autoimmune encephalomyelitis and attenuates reactive gliosis.
The pressing questions in multiple sclerosis Care in the era of COVID-19.
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis.
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
Effects of Ten-Weeks Progressive Resistance Training on Neuromuscular Performance, Mobility, Heart Rate Variability and Sleep Quality in Persons With Multiple Sclerosis
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis.
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS).
A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults.
The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments.
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials.
Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis.
Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey.
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.
Disease-modifying therapy aids cognition in multiple sclerosis.
The Effectiveness of Occupational Therapy-Based Sleep Interventions on Quality of Life and Fatigue in Patients with Multiple Sclerosis: A Pilot Randomized Clinical Trial Study.
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.
Efficacy of the Whole-Body Cryotherapy as Add-on Therapy to Pharmacological Treatment of Depression-A Randomized Controlled Trial.
Absence of miRNA-146a Differentially Alters Microglia Function and Proteome.
B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells.
Analysis of MicroRNA-18a Expression in Multiple Sclerosis Patients.
Interleukin‑1β attenuates the proliferation and differentiation of oligodendrocyte precursor cells through regulation of the microRNA‑202‑3p/β‑catenin/Gli1 axis.
Immune-mediated hepatitis induced by therapy with Alemtuzumab in a patient with Multiple Sclerosis.
A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study.
A fully automated pipeline for brain structure segmentation in multiple sclerosis.
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies.
Patients’ perspective and usability of innovation technology in a new rehabilitation pathway: An exploratory study in patients with multiple sclerosis.
Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient.
Feasibility of “Sit Less, Move More”: An intervention for reducing sedentary behavior Among African Americans with MS.
Brain Activity Changes Following Neuroproprioceptive Physiotherapy in Multiple Sclerosis
Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.
Downregulation of Cancer-Associated lncRNAs in Peripheral Blood of Multiple Sclerosis Patients.
[Family planning in multiple sclerosis: conception, pregnancy, breastfeeding].
Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program.
A model of motivation for physical activity in individuals diagnosed with multiple sclerosis.
Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.
Factors affecting the usability of an assistive soft robotic glove after stroke or multiple sclerosis.
Endeavor™ in Pediatric MS
Can optical flow perturbations detect walking balance impairment in people with multiple sclerosis?
ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation.
Tolerogenic vaccines for the treatment of cardiovascular diseases.
Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome.
Validation of the preference-based multiple sclerosis index.
Functional and structural plasticity following action observation training in multiple sclerosis.
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials.
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.
Month-of-birth-effect in multiple sclerosis in Austria.
Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score.

Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis.
Apoptosis in Autoimmunological Diseases, with Particular Consideration of Molecular Aspects of Psoriasis.
Complementary and Alternative Medicine in Radiotherapy: A Comprehensive Review.
Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years ago.
Effects of a 10-week multimodal dance and art intervention program leading to a public performance in persons with multiple sclerosis – A controlled pilot-trial.
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13.
A new paraplegin mutation in a patient with primary progressive multiple sclerosis.
Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre.
Mobile Attentional Bias Modification Training in Pediatric MS
Maximizing placebo response in neurological clinical practice.
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region.
HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort.
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
Use of Botulinum Toxin in the Genitourinary System.
Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm.
Incidence, prevalence and characteristics of MS in São Miguel, an island in the Atlantic.
Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients.
Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis.
Acute disseminated encephalomyelitis in children and adults: A focused review emphasizing new developments.
microRNAs: key modulators of disease-modifying therapies in multiple sclerosis.
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab.
The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs.
Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients.
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis.
Current application of cannabidiol (CBD) in the management and treatment of neurological disorders.
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort.
[Data on multiple sclerosis in Germany and their representation in the ambulatory registry NeuroTransData (NTD) network].
Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Medication adherence/persistence among patients with active multiple sclerosis in Finland.
Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis.
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS.
Beyond center-based testing: Understanding and improving functioning with wearable technology in MS.
Beyond cognitive dysfunction: Relevance of ecological validity of neuropsychological tests in multiple sclerosis.
Assessing disability and relapses in multiple sclerosis on tele-neurology.
The multiple sclerosis work difficulties questionnaire: translation and cross-cultural adaptation to Turkish and assessment of validity and reliability.
Nurses’ knowledge about perioperative care of patients with neurological diseases.
The protective effect of Helicobacter Pylori infection on the susceptibility of multiple sclerosis.
Role of Viruses in the Pathogenesis of Multiple Sclerosis.
Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.
Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study.
Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients.
MR findings of uterine PEComa in patients with tuberous sclerosis: report of two cases.
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase.
Aging and Brain Atrophy in Multiple Sclerosis.
Safe and successful use of oocyte in-vitro maturation in two infertile women with multiple sclerosis.
Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
Cryptogenic cerebral venous thrombosis in a multiple-sclerosis-patient treated with Alemtuzumab.
A description of Covid-19 modifications to the TEAMS study protocol for remotely delivering teleassessment/teletraining of complementary alternative medicine among people with multiple sclerosis: protocol for a randomized controlled effectiveness trial.
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis.
Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
Intervention for Young Adults With Multiple Sclerosis
Crocus Sativus (Saffron): An Immunoregulatory Factor in the Autoimmune and Non-autoimmune Diseases.
Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: A systematic review and meta-analysis.
Social cognitive theory as a guide for exercise engagement in persons with multiple sclerosis who use wheelchairs for mobility.
Aquatic Therapy in Contemporary Neurorehabilitation: An Update.
Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex.
The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
Identifying Incidence of and Risk Factors for Fluoroscopy-Guided Lumbar Puncture and Subsequent Persistent Low-Pressure Syndrome in Patients With Idiopathic Intracranial Hypertension.
A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders.
Essential medicines for patients with multiple sclerosis.
Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases.
Delta-Globin Gene Expression Is Enhanced in vivo by Interferon Type I.
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy.
Aggressive multiple sclerosis (2): Treatment.
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases.
Use of natural medicine and dietary supplements concomitant with conventional medicine among people with Multiple Sclerosis.
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.
Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosis.
A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env.
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
A Journey to the Conformational Analysis of T-Cell Epitope Peptides Involved in Multiple Sclerosis.
Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis.
Waking Hypnosis in the Treatment of MS-related Fatigue
[Ocrelizumab for treatment of multiple sclerosis].
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study.
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.
Reaching People With Disabilities in Underserved Areas Through Digital Interventions: Systematic Review.
An Italian programme for COVID-19 infection in multiple sclerosis.
Primary cutaneous cryptococcal infection due to fingolimod – Induced lymphopenia with literature review.
Prophylactic and therapeutic roles of oleanolic acid and its derivatives in several diseases.
Tuberous sclerosis complex presenting as primary intestinal lymphangiectasia: A case report.
Nano and Microparticle Emerging Strategies for Treatment of Autoimmune Diseases: Multiple Sclerosis and Type 1 Diabetes.
Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis.
Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study.
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
Pharmacotherapeutic considerations in women with multiple sclerosis.
Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis.

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
Impaired local dynamic stability during treadmill walking predicts future falls in patients with multiple sclerosis: A prospective cohort study.
Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder.
T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis.
Pedometers, the frustrating motivators: a qualitative investigation of users’ experiences of the Yamax SW-200 among people with multiple sclerosis.
Longitudinal biomarkers in amyotrophic lateral sclerosis.
An overview of lipidomic analysis in different human matrices of multiple sclerosis.
Pilates for rehabilitation in patients with multiple sclerosis: A systematic review of effects on cognition, health-related physical fitness, general symptoms and quality of life.
Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.
Self-regulation of brain activity and its effect on cognitive function in patients with multiple sclerosis – First insights from an interventional study using neurofeedback.
An overview of the current state of evidence for the role of specific diets in multiple sclerosis.
Role of B cells and antibodies in multiple sclerosis.
Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study.
Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study.
Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
Arbutin Improves Functional Recovery and Attenuates Glial Activation in Lysolecethin-Induced Demyelination Model in Rat Optic Chiasm.
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.
Breastfeeding and treatment of multiple sclerosis.
Cladribine transfer into human milk: A case report.
Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
Initial User Testing of Decision Aids for Multiple Sclerosis Disease-Modifying Therapies.
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
High-dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy.
Explanatory factors of balance confidence in persons with multiple sclerosis: Beyond the physical functions.
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis.
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers.
Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis.
Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders.
Fibrinolysis induced clinical improvement in a patient with multiple sclerosis exacerbation.
Multiple sclerosis in 2018: new therapies and biomarkers.
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS.
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System.
Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report.
Study Protocol of AMASIA, a Non-Interventional Study to Gain First Insights on SPMS Patients Treated With Siponimod in Clinical Routine.
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.
A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis.
Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases.
Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study.
Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
[Multiple sclerosis : therapy update].
Clinical features and genetic risk of demyelination following anti-TNF treatment.
Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and β1 integrin in treated-multiple sclerosis patients.
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years.
Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis.
Stem cell transplantation and alemtuzumab – options for “early reprogramming” in multiple sclerosis?
Evaluation of NeuroPage as a memory aid for people with multiple sclerosis: A randomised controlled trial.
Progressive resistance exercise training and changes in resting-state functional connectivity of the caudate in persons with multiple sclerosis and severe fatigue: A proof-of-concept study.
Group-based, individualized, comprehensive core stability and balance intervention provides immediate and long-term improvements in walking in individuals with multiple sclerosis: A randomized controlled trial.
Spasticity, gait, and balance in patients with multiple sclerosis: A cross-sectional study.
Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study.
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis.
Telerehabilitation vs Supervised Exercises in MS
Feasibility of a High-intensity Interval Training Program in Persons With Multiple Sclerosis Who Have Walking Disability
Listeria infection after treatment with alemtuzumab: a case report and literature review. Would antibiotic prophylaxis be considered?
Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages.
Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications.
Spiritual health in women with multiple sclerosis and its association with self-esteem.
Cladribine modifies functional properties of microglia.
Effects of aquatic exercises on postural control and hand function in Multiple Sclerosis: Halliwick versus Aquatic Plyometric Exercises: a randomised trial.
Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats.
Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study.
Comparing the Effectiveness of Computer-Based, Manual-based, and Combined Cognitive Rehabilitation on Cognitive Functions in Relapsing-Remitting Multiple Sclerosis Patients.
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosis.
Efficacy and safety of rituximab in multiple sclerosis: Experience from a developing country.
Emerging small-molecule treatments for multiple sclerosis: focus on B cells.
Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
Bacterial transportable toxins of the nasopharyngeal microbiota in multiple sclerosis. Nose-to-brain direct.
Clinical Characteristics of Multiple Sclerosis in African-Americans.
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis.
Ocrelizumab-induced alopecia areata-A series of five patients from Ontario, Canada: A case report.
Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies.
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton’s Tyrosine Kinase (BTK) Inhibitor SAR442168
DreaMS – Digital Biomarkers for Multiple Sclerosis
Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice.
Congenital lymphedema as a rare and first symptom of tuberous sclerosis complex.
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Neuropsychological assessments and psychotherapeutic services in Veterans with multiple sclerosis: Rates of utilization and their associations with socio-demographics and clinical characteristics using Veterans Health Administration-based data.
Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese Relapsing Multiple Sclerosis Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury.
The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis.
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.
Exercise improves neurotrophins in multiple sclerosis independent of disability status.
Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis.
Anti-CD6 mAbs for the treatment of psoriasis.
[Development of an indicator set for the evaluation of the population-based integrated healthcare model ‘Gesundes Kinzigtal’ (Healthy Kinzigtal)].
Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design).
EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis.
EAN guideline on palliative care of people with severe, progressive multiple sclerosis.

Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS.
DCLK-1 LEVEL IN MULTIPLE SCLEROSIS PATIENTS AND ITS CORRELATION WITH CLINIC.
A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods.
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.
Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury
Treatment of multiple sclerosis under the COVID-19 pandemic.
Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate.
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
Helminths products directly modulate T cells that mediate experimental autoimmune encephalomyelitis.
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
Spinal Cord Involvement in MS and Other Demyelinating Diseases.
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis.
Inflammation-related plasma and CSF biomarkers for multiple sclerosis.
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers.
Impact of Age on Multiple Sclerosis Disease Activity and Progression.
Antifungal itraconazole ameliorates experimental autoimmune encephalomyelitis through a novel mechanism of action.
[Relationship between parasitic infections and hygiene hypothesis: a review].
Frailty in ageing persons with multiple sclerosis.
Remyelination alters the pattern of myelin in the cerebral cortex.
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT
CD49d/CD29-integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation.
Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center.
Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway.
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review.
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Machine Learning and Multiparametric Brain MRI to Differentiate Hereditary Diffuse Leukodystrophy with Spheroids from Multiple Sclerosis.
Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study.
Severe skin reactions associated with cladribine in people with multiple sclerosis.
Phytotherapy as a Complementary Medicine for Multiple Sclerosis.
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development.
Multimodal Image Analysis for Assessing Multiple Sclerosis and Future Prospects Powered by Artificial Intelligence.
Living Donor Preemptive Kidney Transplantation in Tuberous Sclerosis Complex Patient and the Role of Mammalian Target of Rapamycin Inhibitor: A Case Report.
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.
Construct validity of the Gait Assessment and Intervention Tool (GAIT) in people with Multiple Sclerosis.
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab.
Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis.
Targeting macrophages by an aza-anthrapyrazole to ameliorate experimental autoimmune encephalomyelitis.
Neurofilaments in progressive multiple sclerosis: a systematic review.
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression.
Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis.
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.
Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies.
Better Objective Sleep Was Associated with Better Subjective Sleep and Physical Activity; Results from an Exploratory Study under Naturalistic Conditions among Persons with Multiple Sclerosis.
Factors affecting outcome in frameless non-isocentric stereotactic radiosurgery for trigeminal neuralgia: a multicentric cohort study.
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx).
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
Caregiver Burden in Multiple Sclerosis: Recent Trends and Future Directions.
Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?
Epigenetics in Multiple Sclerosis.
Biocompatible nanovesicular drug delivery systems with targeting potential for autoimmune diseases.
A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis.
Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report.
Multiple Sclerosis Performance Test: Technical Development and Usability.
Participation in and outcomes from a 12-month tailored exercise programme for people with multiple sclerosis (MSTEP©): a randomized trial.
High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates.
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy.
Stress cardiomyopathy associated with area postrema syndrome as a presentation of neuromyelitis optica: case report.
Laquinimod Protects Against TNF-α-Induced Attachment of Monocytes to Human Aortic Endothelial Cells (HAECs) by Increasing the Expression of KLF2.
Genus Boswellia as a new candidate for neurodegenerative disorders.
CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
[Effects of rehabilitation on fatigue, disability and quality of life in people with multiple sclerosis: A systematic review].
Curcumin and neurological diseases.
Engagement of people with multiple sclerosis to enhance research into the physiological effect of hyperbaric oxygen therapy.
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina.
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta.
A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.
The protective effects of phoenixin-14 against lipopolysaccharide-induced inflammation and inflammasome activation in astrocytes.
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy.
Structural changes in the brain of patients with relapsing-remitting multiple sclerosis compared to controls: a MRI-based stereological study.
Neuroplasticity and brain reorganization associated with positive outcomes of multidisciplinary rehabilitation in progressive multiple sclerosis: A fMRI study.
Dimethyl fumarate modulates the Treg:Th17 cell axis in psoriasis patients.
Molecular Interventions towards Multiple Sclerosis Treatment.
Investigating the Causal Effect of Brain Expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 Genes on Multiple Sclerosis: A Two-Sample Mendelian Randomization Approach.
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
Regulatory B cells normalize CNS myeloid cell content in a mouse model of multiple sclerosis and promote oligodendrogenesis and remyelination.
Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
Ultrasonographic evaluation of the diaphragm thickness in patients with multiple sclerosis.
Predictors of people’s perceptions of second hand smoke exposure as a risk factor for multiple sclerosis.
Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability.
Compared to an active control condition, in persons with multiple sclerosis two different types of exercise training improved sleep and depression, but not fatigue, paresthesia, and intolerance of uncertainty.
Early initiation of fingolimod reduces the rate of severe relapses over the long term: Post hoc analysis from the FREEDOMS, FREEDOMS II, and TRANSFORMS studies.
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase.
Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspective.
BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT®.
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis.
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE.
Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation.
Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
Comparison of brain atrophy in multiple sclerosis patients treated with first generation disease modifying therapy without clinical relapse.
A possible case of serum sickness after ocrelizumab infusion.
Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.
Medication beliefs in first-line and second-line treated multiple sclerosis patients.
Aquatic exercising may improve sexual function in females with multiple sclerosis – an exploratory study.

Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis.
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple Sclerosis.
Dietary interventions for multiple sclerosis-related outcomes.
An antimicrobial impregnated urinary catheter that reduces mineral encrustation and prevents colonisation by multi-drug resistant organisms for up to 12 weeks.
Exercise intensity-dependent immunomodulatory effects on encephalomyelitis.
Cerebellar White Matter Damage Is Associated With Postural Sway Deficits in People With Multiple Sclerosis.
Video-Based Pairwise Comparison: Enabling the Development of Automated Rating of Motor Dysfunction in Multiple Sclerosis.
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection.
The Combination Of Rtms And Pharmacotherapy On In Vitro Models: A Mini Review.
Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology.
Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing – Remitting Multiple Sclerosis.
Aggressive multiple sclerosis: a single center, real-world treatment experience: aematopoietic stem cell transplantation and alemtuzumab.
CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis.
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19.
Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis.
The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis.
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.
Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis.
The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis: A Narrative Review and Canadian Regional Reimbursement Policies.
Lipid and Lipoprotein Metabolism in Microglia.
Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.
The Successful Treatment of Severe Trigeminal Neuralgia by a Single Mandibular Nerve Block and Subsequent Natalizumab Administration in a Patient with Multiple Sclerosis.
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Sensory-motor network topology in multiple sclerosis: Structural connectivity analysis accounting for intrinsic density discrepancy.
Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study.
Introduction to the Theme “New Therapeutic Targets”.
All-cause hospitalizations in multiple sclerosis patients.
Autoantibodies in Pandemrix®-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test.
Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.
Multiple sclerosis in ophthalmology: beyond optic neuritis.
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.
Optical coherence tomography use in idiopathic intracranial hypertension.
Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP).
Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review.
Inadvertent Antegrade Urethral Placement of a Suprapubic Catheter.
Time Restricted Eating Outcomes in Multiple Sclerosis
Entire-body PET Scans for Multiple Sclerosis
Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory study.
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.
Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis.
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
The Effect of Nurse Practitioner (NP-led) Care on Mood, Anxiety and Health Related Quality of Life in People With Multiple Sclerosis – A Randomized Trial
Effects of Ocrevus in Relapsing Multiple Sclerosis
Social Media Surveillance of Multiple Sclerosis Medications Used During Pregnancy and Breastfeeding: Content Analysis.
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
Treatment of neurogenic lower urinary tract symptoms: main contributions from 2018 and 2019.
An Expert Patient Program as a Tool to Empower People With Multiple Sclerosis.
The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients.
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in Sweden.
Therapeutic effect of Omega-3 fatty acids on T cell-mediated autoimmune diseases.
Concerns about the safety of anti-TNF agents when treating rheumatic diseases.
Lung-Resident Mesenchymal Stromal Cells are Tissue-Specific Regulators of Lung Homeostasis.
Alemtuzumab and prescription medication use in the MS population.
Real-world incidence of fingolimod-associated macular oedema.
Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Medical Therapeutic Yoga for multiple sclerosis: examining self-efficacy for physical activity, motivation for physical activity, and quality of life outcomes.
Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial.
Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice.
Pathogenicity of BK virus on the urinary system.
Neuroprotective natural products against experimental autoimmune encephalomyelitis: A review.
A systematic review of aerobic and resistance exercise and inflammatory markers in people with multiple sclerosis.
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate.
The effect of tDCS on the fatigue in patients with multiple sclerosis: A systematic review of randomized controlled clinical trials.
[12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)].
Exercise training and cognitive performance in persons with multiple sclerosis: A systematic review and multilevel meta-analysis of clinical trials.
Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Epidemiology of multiple sclerosis IN Santiago de Compostela (Spain).
Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis.
Influence of RehaCom Therapy on the Improvement of Manual Skills in Multiple Sclerosis Subjects.
Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier.
Problems and Pitfalls of Identifying Remyelination in Multiple Sclerosis.
Optic nerve atrophy and whole and regional brain atrophy in Leber’s hereditary optic neuropathy with multiple sclerosis-like disease with m.11778G>A mutation.
Walking and cognitive performance in adults with multiple sclerosis: Do age and fatigability matter?
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature.
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
Symbol Digit Modalities Test: Greek Normative Data for the Oral and Written Version and Discriminative Validity in Patients with Multiple Sclerosis.
New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
Ozanimod: First Approval.
Pharmacotherapeutic Options for Managing Pain in Multiple Sclerosis.
Early clinical markers of aggressive multiple sclerosis.
Personal Autonomy as Quality of Life Predictor for Multiple Sclerosis Patients.
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
[Magnetic Resonance Imaging of Multiple Sclerosis].
[New Arrival of Disease Modifying Drugs Initiates New Era in Multiple Sclerosis Treatment in Japan].
Randomized comparison of functional electric stimulation in posturally corrected position and motor program activating therapy: treating foot drop in people with multiple sclerosis.
SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad.
Lower urinary tract dysfunction in common neurological diseases.
Real-Word Effectiveness and Safety of Dimethyl Fumarate in a Multiple Sclerosis Portuguese Population.
Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: a social return on investment study.
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
A new lower limb portable exoskeleton for gait assistance in neurological patients: a proof of concept study.

Choroid plexus and the blood-cerebrospinal fluid barrier in disease.
Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4+ T cell apoptosis.
Micro-percutaneous nephrolithotomy (Microperc) for renal stones, outcomes and learning curve.
Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
Sugammadex for Cesarean in a Patient with Multiple Sclerosis.
Mindfulness training for emotion dysregulation in multiple sclerosis: A pilot randomized controlled trial.
Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis: Secondary Analysis of a Randomized Clinical Trial.
Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis.
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic.
Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation.
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study.
Treatment and management of cognitive dysfunction in patients with multiple sclerosis.
Cognitive disturbances in the cuprizone model of multiple sclerosis.
The Effects of Evening Primrose/Hemp Seed Oil Compared to Rapamycin on the Gene Expression of Immunological Parameters in Experimental Autoimmune Encephalomyelitis Splenocytes.
Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.
SUNLIGHT Study: Online Support Groups for MS to Address COVID-19
Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Serum Level of Neuroactive Steroids
Predicting the Disease Genes of Multiple Sclerosis Based on Network Representation Learning.
Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study.
FCRL3 promotes IL-10 expression in B cells through the SHP-1 and p38 MAPK signalling pathways.
Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis.
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab
The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
DeepHarmony: A deep learning approach to contrast harmonization across scanner changes.
Computerized Cognitive Training in Multiple Sclerosis: A Systematic Review and Meta-analysis.
“Taming the Beast”: Exploring the Lived Experience of Relapsing Remitting Multiple Sclerosis Using a Life History Approach.
IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.
[MS update: risk factors, diagnosis and treatment].
RehaCom rehabilitation training improves a wide-range of cognitive functions in multiple sclerosis patients.
Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis.
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019).
Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.
A comprehensive review of non-coding RNAs functions in multiple sclerosis.
Alendronate alleviates the symptoms of experimental autoimmune encephalomyelitis.
Oral chitin treatment improved demyelination in murine autoimmune encephalomyelitis model by inhibition of inflammatory responses.
The IN-DEEP project “INtegrating and Deriving Evidence, Experiences, Preferences”: a web information model on magnetic resonance imaging for people with multiple sclerosis.
Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review.
Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis.
Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?
Neurons promote encephalitogenic CD4+ lymphocyte infiltration in experimental autoimmune encephalomyelitis.
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
Mobility Disorders in Stroke, Parkinson Disease, and Multiple Sclerosis: A Multicenter Cross-Sectional Study.
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study.
Experience with rituximab therapy in a real-life sample of multiple sclerosis patients.
Role of long non-coding RNAs (LncRNAs) in multiple sclerosis: a brief review.
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation.
Exercise in the management of multiple sclerosis relapses: current evidence and future perspectives.
Effects of 4-week mindfulness training versus adaptive cognitive training on processing speed and working memory in multiple sclerosis.
MOSPD2 is a Therapeutic Target for the Treatment of CNS Inflammation.
Natural Product Piperine Alleviates Experimental Allergic Encephalomyelitis in Mice by Targeting Dihydroorotate Dehydrogenase.
Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort.
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study).
Short Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1)
Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia
On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells.
Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four Case Reports and a Literature Review.
A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone.
Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosis.
A Phase 1 Study of KHK4827 in Patients With Systemic Sclerosis
Sensor-based Technology for Upper Limb Rehabilitation
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis
Walking to Music and Metronome at Various Tempi in Persons With Multiple Sclerosis: A Basis for Rehabilitation.
Finding a Way Out: S1P Signaling and Immune Cell Migration.
Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report.
The Multiple Sclerosis Surveillance Registry: A Novel Interactive Database Within the Veterans Health Administration.
Behavioral Interventions in Multiple Sclerosis.
Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System.
The Future of Progressive Multiple Sclerosis Therapies.
β-Amyloid precursor protein (APP) and the human diseases.
Exercise and Multiple Sclerosis.
Design, Development, and Testing of an App for Dual-Task Assessment and Training Regarding Cognitive-Motor Interference (CMI-APP) in People With Multiple Sclerosis: Multicenter Pilot Study.
An update on the pharmacological management of pain in patients with multiple sclerosis.
Social participation of patients with multiple sclerosis.
Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials.
Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
A Neuropsychological Rehabilitation Program for Cognitive Impairment in Psychiatric and Neurological Conditions: A Review That Supports Its Efficacy.
Danish Physicians’ Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative Study.
Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
Exercise experiences among persons with multiple sclerosis living in the southeast of the United States.
Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres.
Real-world cost of treatment for multiple sclerosis patients initiating and receiving infused disease-modifying therapies per recommended label in the United States.
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination.
Safety and efficacy of memantine for multiple sclerosis-related fatigue: A pilot randomized, double-blind placebo-controlled trial.
Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Multiple Sclerosis Treatment and Melanoma Development.
[Core aspects of a needs-conform care of patients with multiple sclerosis : Utilization of outpatient services and shared decision making].
Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial.
The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study.
Effects of robot-assisted gait training combined with virtual reality on motor and cognitive functions in patients with multiple sclerosis: A pilot, single-blind, randomized controlled trial.
Clinical outcome measures in multiple sclerosis: A review.

TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice.
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring.
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder.
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases.
Activity of Antioxidant Defense Enzymes in Rats with Experimental Allergic Encephalomyelitis.
[EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic].
Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis.
Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate.
Fistulas healing. Stable gastric pentadecapeptide BPC 157 therapy.
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration.
Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course.
Teriflunomide, a potential novel cause of chronic active colitis.
Risk Factors for Suicide in a National Sample of Veterans with Multiple Sclerosis.
Management of multiple sclerosis symptoms through reductions in sedentary behaviour: protocol for a feasibility study.
Functional Mobility and Basic Motor Skills in Patients with Multiple Sclerosis and Its Relation to the Anthropometrical Status and Body Composition Parameters.
Live birth in women with multiple sclerosis receiving assisted reproduction.
Matrix decomposition for modeling lesion development processes in multiple sclerosis.
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study.
Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol.
Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial.
Training and Energy Management Education to Improve Quality of Life in Persons With Multiple Sclerosis
[The microbiota-gut-brain axis and its great projections].
Medically Refractory Multiple Sclerosis Is Successfully Treated with Plasmapheresis in a Super Morbidly Obese Pregnant Patient.
Spectrum of anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases: an Indian perspective.
An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®.
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
[New directions of immunocorrection in multiple sclerosis].
Identification of Concepts of Spiritual Care in Iranian Peoples with Multiple Sclerosis: A Qualitative Study.
Rapid evidence assessment of approaches to community neurological nursing care for people with neurological conditions post-discharge from acute care hospital.
Patient Attitudes to Routine Cognitive Testing in Multiple Sclerosis.
Neuromyelitis optica spectrum disorders.
A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.
Potential therapeutic applications of exosomes in different autoimmune diseases.
Moderator Effects in Intervention Studies.
From molecular mechanism to pre-clinical results: Anti-epileptic effects of Fingolimod.
From Charcot’s descriptions to the current understanding of neuropsychiatric symptoms in multiple sclerosis.
Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [synopsis].
Neuroproprioceptive “Facilitation, Inhibition” and Brain Plasticity
Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis.
Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [commentary].
Exercise Interventions for Improving Flexibility in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
The effect of IFN-β 1a on expression of MDA5 and RIG-1 in Multiple Sclerosis patients.
MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis.
Modulating the immune response with the wake-promoting drug modafinil: a potential therapeutic approach for inflammatory disorders.
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab
Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.
Sex-selective effects on behavior in a mouse model of Tuberous Sclerosis Complex.
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis.
Advances in physical rehabilitation of multiple sclerosis.
Evaluation of cell transplant-mediated attenuation of diffuse injury in experimental autoimmune encephalomyelitis using onVDMP CEST MRI.
Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis.
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum.
NAD+ Attenuates Experimental Autoimmune Encephalomyelitis through Inducing of CD11b+ gr-1+ Myeloid-Derived Suppressor Cells.
Modified Delphi study of decision-making around treatment sequencing in relapsing-remitting multiple sclerosis.
Introduction to Purinergic Signaling.
Therapeutic effects of Crocin in autoimmune diseases: A review.
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis.
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients.
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
An examination of the effects of a patient-designed-and-informed participant information sheet in comparison with a standard, researcher-designed information sheet on recruitment, retention and understanding: Protocol for a study-within-a-trial.
Benefits of Physical Activity for Depression and Fatigue in Multiple Sclerosis: A Longitudinal Analysis.
Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study.
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative Review.
Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and from the scientific community.
Ocular involvement in systemic sclerosis: A systematic literature review, it’s not all scleroderma that meets the eye.
Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review.
Spousal support and self-determined physical activity in individuals with multiple sclerosis: A theory-informed qualitative exploration.
Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila.
Is Initial Misdiagnosis Associated with Reaching Disability Milestones in Patients with Multiple Sclerosis?
Nimodipine reduces dysfunction and demyelination in models of multiple sclerosis.
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Multiple Sclerosis in Children: Current and Emerging Concepts.
Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.
Smoking as a risk factor of onset and relapse of Multiple Sclerosis – a review.
Nocebo and its effects in dentistry and dental research.
Intrinsic and extrinsic mechanisms of thalamic pathology in multiple sclerosis.
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis.
Discovery of a 2-pyridinyl urea-containing compound YD57 as a potent inhibitor of apoptosis signal-regulating kinase 1 (ASK1).
Matching and accepting assistive technology in multiple sclerosis: A focus group study with people with multiple sclerosis, carers and occupational therapists.
Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.
HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab.
Breastfeeding in the Multiple Sclerosis Patient.
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study.
Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Validity and Reliability Study of the Turkish Version of Multiple Sclerosis Self-Management Scale.
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
A review of possible therapies for Parkinson’s disease.
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.
The immediate effect of stroboscopic visual training on information-processing time in people with multiple sclerosis: an exploratory study.
Anti-N-methyl-D-aspartate receptor encephalitis during treatment with adalimumab for psoriasis.
Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients.
Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis.
Single-pulse transcranial magnetic stimulation in amyotrophic lateral sclerosis.
Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.

Monitoring of radiologic disease activity by serum neurofilaments in MS.
[Intermediate Uveitis in Adults and Children – Update].
Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD).
Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis.
IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study.
How and for whom does supportive adjustment to multiple sclerosis cognitive-behavioural therapy work? A mediated moderation analysis.
Pilot study of social cognitive theory variables as correlates of physical activity among adolescents with pediatric multiple sclerosis.
Proteomic changes during experimental de- and remyelination in the corpus callosum.
Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
Commentary: One Hundred Eleven Percutaneous Balloon Compressions for Trigeminal Neuralgia in a Cohort of 66 Patients with Multiple Sclerosis.
The Effectiveness of Percutaneous Balloon Compression, Thermocoagulation, and Glycerol Rhizolysis for Trigeminal Neuralgia in Multiple Sclerosis.
A Higher Mediterranean Diet Score, Including Unprocessed Red Meat, Is Associated with Reduced Risk of Central Nervous System Demyelination in a Case-Control Study of Australian Adults.
Migraine in 746 patients with multiple sclerosis.
UV light suppression of EAE (a mouse model of multiple sclerosis) is independent of vitamin D and its receptor.
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Yes.
Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17.
Microglia in Multiple Sclerosis: Friend or Foe?
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders.
Fecal Microbiota Transplantation in Neurological Disorders.
Validity and Reliability of the World Health Organization Disability Assessment Schedule 2.0 36-Item Persian Version for Persons with Multiple Sclerosis.
Menopause in women with multiple sclerosis: A systematic review.
A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis.
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis
Gray matter network reorganization in multiple sclerosis from 7-Tesla and 3-Tesla MRI data.
Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis – Randomized clinical trial.
The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms.
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options.
Measuring upper limb function in MS: Which existing patient reported outcomes are fit for purpose?
Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity.
Laquinimod inhibits MMP+ induced NLRP3 inflammasome activation in human neuronal cells.
Regulation of Stem Cell-Based Research in India in comparison with the US,EU other Asian countries: Current Issues and Future Perspectives.
Straighten your back! Self-correction posture and postural balance in “non rehabilitative instructed” multiple sclerosis patients.
An intensive task-oriented circuit training positively impacts gait biomechanics in MS patients.
The window of opportunity for treatment of progressive multiple sclerosis.
Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis.
The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives.
Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection – A Multicenter Experience.
Possible therapies of Parkinson’s disease: A review.
Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis.
Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response.
Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation.
The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation.
IL-2 and Mycobacterial Lipoarabinomannan as Targets of Immune Responses in Multiple Sclerosis Patients.
A Randomized Control Trial Study to Determine the Effect of Melatonin on Serum Levels of IL-1β and TNF-α in Patients with Multiple Sclerosis.
Oral therapies for treatment of relapsing-remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method.
Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS.
Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS.
Adaptation to repeated gait-slip perturbations among individuals with multiple sclerosis.
Construct validity and test-retest reliability of the Swedish version of the Acceptance of Chronic Health Conditions Scale.
The rate of neuropsychological assessments in multiple sclerosis has increased-A retrospective study in a Finnish Central Hospital.
The brain-heart connection: a multiple sclerosis relapse presenting as Takotsubo Syndrome. A case report and literature review.
Dense module searching for gene networks associated with multiple sclerosis.
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.
Facial pain – an interdisciplinary challenge
Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
Long-term MS secondary progression: Derivation and validation of a clinical risk score.
Deployment o the Multidisciplinary Prospective Cohort Imminent
Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
Effects of Whole-Body Vibration on Motor Impairments in Patients With Neurological Disorders: A Systematic Review.
Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis.
Physical activity and walking performance across the lifespan among adults with multiple sclerosis.
Higher health care use before a clinically isolated syndrome with or without subsequent MS.
Accessing palliative care for multiple sclerosis: A qualitative study of a neglected neurological disease.
Continuous 12 min walking to music, metronomes and in silence: Auditory-motor coupling and its effects on perceived fatigue, motivation and gait in persons with multiple sclerosis.
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study.
Vocal wow in an adapted reflex resonance model.
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
Informing MS patients on treatment options: a consensus on the process of consent taking.
Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
On the path together: Experiences of partners of people with multiple sclerosis of the impact of lifestyle modification on their relationship.
Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study.
Do subcortical gray matter volumes and aerobic capacity account for cognitive-motor coupling in multiple sclerosis?
Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review.
Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis.
Current Advances in Pediatric Onset Multiple Sclerosis.
Distribution of Cortical Diffusion Tensor Imaging Changes in Multiple Sclerosis.
A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis.
Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.
Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation.
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.
pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.
Neuronal vulnerability and multilineage diversity in multiple sclerosis.
Bilateral paramedian pontine infarcts: a rare cause of bilateral horizontal gaze palsy.
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.
Predictors of hospitalization in a Canadian MS population: A matched cohort study.
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab.
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.
Paraneoplastic tumefactive demyelination in a 47-year-old man with underlying seminoma.
CNS-localized myeloid cells capture living invading T cells during neuroinflammation.

Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland.
Daily Temporal Associations Between Physical Activity and Symptoms in Multiple Sclerosis.
Validity of sitting time scores from the International Physical Activity Questionnaire-Short Form in multiple sclerosis.
Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient.
Optimization of tetrahydroindazoles as inhibitors of human dihydroorotate dehydrogenase and evaluation of their activity and in vitro metabolic stability.
“Ode to confidence”: Poetry groups for dysarthria in multiple sclerosis.
Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens.
Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study.
Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod.
The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice.
Drug targeting strategies into the brain for treating neurological diseases.
A Controlled Clinical Trial on the Effects of Exercise on Lower Urinary Tract Symptoms in Women With Multiple Sclerosis.
Exercise Interventions for Individuals With Neurological Disorders: A Systematic Review of Systematic Reviews.
Opposing T cell responses in experimental autoimmune encephalomyelitis.
Kappa opioid receptor and oligodendrocyte remyelination.
[Non continent urinary diversion and other bladder managements in patients with multiple sclerosis].
Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders.
Letter to the Editor Regarding “Possible Prognostic Role of Magnetic Resonance Imaging Findings in Patients with Trigeminal Neuralgia and Multiple Sclerosis who Underwent Percutaneous Balloon Compression: Report of Our Series and Literature Review”.
In Reply to the Letter to the Editor Regarding “Possible Prognostic Role of Magnetic Resonance Imaging Findings in Patients with Trigeminal Neuralgia and Multiple Sclerosis Who Underwent Percutaneous Balloon Compression: Report of Our Series and Literature Review”.
Device-Measured Physical Activity and Cognitive Processing Speed Impairment in a Large Sample of Persons with Multiple Sclerosis.
Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment.
Effects of Transcranial Direct Current Stimulation on Hand Dexterity in Multiple Sclerosis: A Design for a Randomized Controlled Trial.
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization.
Unsupervised Domain Adaptation With Optimal Transport in Multi-Site Segmentation of Multiple Sclerosis Lesions From MRI Data.
Cognitive Impairment and Brain Reorganization in MS: Underlying Mechanisms and the Role of Neurorehabilitation.
Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
Feature selection based on differentially correlated gene pairs reveals the mechanism of IFN-β therapy for multiple sclerosis.
Randomized controlled trial of physical activity intervention effects on fatigue and depression in multiple sclerosis: Secondary analysis of data from persons with elevated symptom status.
Mental Practice and Manipulative Skills Training in Multiple Sclerosis
Multiple Doses of AT-1501-A201 in Adults With ALS
A new target for the treatment of inflammatory bowel disease: Interleukin-37.
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.
Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability.
Endogenous spinal cord stem cells in multiple sclerosis and its animal model.
Immunology of oligodendrocyte precursor cells in vivo and in vitro.
Natalizumab induced cutaneous sarcoidosis-like reaction.
Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.
Commentary: “Brave Dreams” Reanalysis Sheds New Light on Angioplasty for Venous Anomalies in Some Multiple Sclerosis Patients With Chronic Cerebrospinal Venous Insufficiency.
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity.
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis.
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.
Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient.
Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history.
A Self-management Program to Prevent Falls in People With Multiple Sclerosis
Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis.
Trunk and pelvis movement compensation in people with multiple sclerosis: Relationships to muscle function and gait performance outcomes.
Efficacy of robot-assisted gait training in multiple sclerosis: A systematic review and meta-analysis.
Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update.
Application of the 2017 McDonald criteria for the diagnosis of multiple sclerosis after a first demyelinating event in patients from Argentina.
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model.
Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis.
Measuring Quality-Adjusted Life-Years When Health Fluctuates.
Neuroprotection Induced by Dexpramipexole Delays Disease Progression in a Mouse Model of Progressive Multiple Sclerosis.
Rethinking multiple sclerosis treatment strategies.
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta.
Design and characterization of a novel structural class of Kv1.3 inhibitors.
Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature.
The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era.
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population.
Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients.
LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.
Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis.
Epidemiology of multiple sclerosis in Central Europe, update from Hungary.
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.
The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
The role of chemokines and chemokine receptors in multiple sclerosis.
Peripheral nerve field stimulation in medically refractory trigeminal neuralgia attributed to multiple sclerosis.
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12-month) follow-up at one site.
Pure spinal multiple sclerosis: A possible novel entity within the multiple sclerosis disease spectrum.
A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit.
Lifetime exposure to ultraviolet radiation and the risk of multiple sclerosis in the US radiologic technologists cohort study.
Five years before multiple sclerosis onset: Phenotyping the prodrome.
Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial.
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.
Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.
The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.
The transcription factor Nurr1 is up-regulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.
Neurofilament Protein as a Potential Biomarker of Axonal Degeneration in Experimental Autoimmune Encephalomyelitis.
Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications.
Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice.
Oxygen Cost During Mobility Tasks and Its Relationship to Fatigue in Progressive Multiple Sclerosis.
Randomized Controlled Trial of a Telephone-Delivered Physical Activity and Fatigue Self-management Interventions in Adults With Multiple Sclerosis.
The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis.
Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial.
Protective effects of catalpol and rhein in murine experimental autoimmune encephalomyelitis via regulation of T helper (Th) 1, Th2, Th17, and regulatory T cell responses.
Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain: Second-Line GATE Study.
Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies.
Rhythmic Auditory Stimulation & Gait Training
Data of safety in a single-center alemtuzumab treated population.
Gait Variability, Not Walking Speed, Is Related to Cognition in Adolescents With Multiple Sclerosis.
Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.
Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88.
Effectiveness of rehabilitation interventions for people with multiple sclerosis – A Cochrane Review summary with commentary.
Accessible exercise equipment and individuals with multiple sclerosis: Aerobic demands and preferences.

Different roles of soluble CD40 ligand in central nervous system damage.
Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.
Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders.
Comparison of rituximab originator (MabThera®) to biosimilar (Truxima®) in patients with multiple sclerosis.
Information Needs and Seeking Behavior of Italian Neurologists: Survey Describing Needs and Resources in Two Different Clinical Settings.
The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study.
Recombinant adenosine deaminase ameliorates inflammation, vascular disease and fibrosis in preclinical models of systemic sclerosis.
Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Novel phloroglucinol derivative Compound 21 protects experimental autoimmune encephalomyelitis rats via inhibiting Th1/Th17 cell infiltration.
MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.
Percutaneous Venous Angioplasty in Patients with Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency: A Randomized Wait List Control Study.
Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts – the CONFIDENCE study protocol.
The influence of vitamin D on neurodegeneration and neurological disorders: a rationale for its physio-pathological actions.
Transplantation of IFN-γ Primed hUCMSCs Significantly Improved Outcomes of Experimental Autoimmune Encephalomyelitis in a Mouse Model.
Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis.
Physical activity interventions can improve emotion regulation and dimensions of empathy in persons with multiple sclerosis: An exploratory study.
Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis.
An alternative to product-specific pregnancy registries? PRIM; PRegnancy outcomes Intensive Monitoring.
RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation.
Use of the Godin leisure-time exercise questionnaire in multiple sclerosis research: a comprehensive narrative review.
Food allergies are associated with increased disease activity in multiple sclerosis.
IL-17 and limits of success.
Minimally invasive asterional approach for microvascular decompression in trigeminal neuralgia.
Neuroinflammation: an overview of neurodegenerative and metabolic diseases and of biotechnological studies.
Targeted Kruppel-like factor 4 gene knockout in retinal ganglion cells improves visual function in multiple sclerosis mouse model.
Progression of Anterograde Trans-Synaptic Degeneration in the Human Retina Is Modulated by Axonal Convergence and Divergence.
A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity.
Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.
Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status.
Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes.
Therapeutic intervention in relapsing autoimmune demyelinating disease through induction of myelin-specific regulatory CD8 T cell responses.
Exercise Training Guidelines for Multiple Sclerosis, Stroke, and Parkinson Disease: Rapid Review and Synthesis.
Stem Cells: A Review Encompassing the Literature with a Special Focus on the Side-Lined Miraculous Panacea; Pre-Morula Stem Cells.
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.
Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis.
Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis.
Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research.
Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience.
Vitamin D and Disease Severity in Multiple Sclerosis-Baseline Data From the Randomized Controlled Trial (EVIDIMS).
Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody.
A model of different cognitive processes during spontaneous and intentional coupling to music in multiple sclerosis.
Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models.
Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases.
Interventions for preventing falls in people with multiple sclerosis.
Affective Disorder and Functional Status as well as Selected Sociodemographic Characteristics in Patients with Multiple Sclerosis, Parkinson’s Disease and History of Stroke.
Sexual Dysfunction and Depression in Patients with Multiple Sclerosis in Croatia.
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism.
Exercise to Manage Fatigue in Progressive Multiple Sclerosis
Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosis.
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases.
Peripheral levels of selected adipokines in patients with newly diagnosed multiple sclerosis.
Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis.
Motor Neurone Disease – Systematic Multi-Arm Adaptive Randomised Trial
Another brick in the wall: further evidence supporting the role of haematopoietic stem cell transplantation in treating multiple sclerosis.
Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.
Neurocognitive and emotional status after one-year of mindfulness-based intervention in patients with relapsing-remitting multiple sclerosis.
The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient Empowerment.
Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
Coping and Adjusting to Living With Multiple Sclerosis
Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses.
Lichenoid rash: A new side effect of oral Cladribine.
The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis.
Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease.
‘I can do this’: a qualitative exploration of acceptability and experiences of a physical activity behaviour change intervention in people with multiple sclerosis in the UK.
Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial.
Effect of Rituximab on Expanded Disability Status Scale and Relapse Rate in Multiple Sclerosis Patients.
Alemtuzumab for relapsing multiple sclerosis in clinical practice: A four-year retrospective one-center study.
Haptic vs sensorimotor training in the treatment of upper limb dysfunction in multiple sclerosis: A multi-center, randomised controlled trial.
Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders.
Fatigue Profiles in Patients with Multiple Sclerosis are Based on Severity of Fatigue and not on Dimensions of Fatigue.
Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges.
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review.
Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients.
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study.
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study.
Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study.
Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis.
Perceived Treatment Satisfaction and Effectiveness Facilitators Among Patients With Chronic Health Conditions: A Self-Reported Survey.
[PROGNOSTIC VALUE OF BIOMARKERS OF MULTIPLE SCLEROSIS ACTIVITY].
Scope and Applications of Nanomedicines for the Management of Neuropathic Pain.
Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosis.
First approved treatment in children with multiple sclerosis slows brain atrophy.
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort.
What role should spinal cord MRI take in the future of multiple sclerosis surveillance?
Healing hand ulcers caused by focal spasticity.
Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis.
Dynamic expression of JC virus in urine and its relationship to serostatus.
Exposure to Ultraviolet Radiation in the Modulation of Human Diseases.
Siponimod to treat secondary progressive multiple sclerosis.
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) – preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis.
White matter lesion location correlates with disability in relapsing multiple sclerosis.
Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations.
Tumefactive Acute Disseminated Encephalomyelitis.
Social Cognition Impairments in Patients with Multiple Sclerosis: Comparison with Grade of Disability.
Use of rituximab in adults with relapsing-remitting multiple sclerosis: a systematic literature review.

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.
Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).
Exercise Therapy in Multiple Sclerosis
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis.
DEL-1-Regulated Immune Plasticity and Inflammatory Disorders.
A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.
[Causes and predictive factors of prolonged length of hospital stay after flexible ureteroscopy: Experience of a large volume institution].
Cognitive Behavioral Therapy for the Management of Multiple Sclerosis-Related Pain: A Randomized Clinical Trial.
Changes in Activity Participation After Multiple Sclerosis Diagnosis.
The Multiple Sclerosis Self-Management Scale-Revised (MSSM-R): Persian Version and Psychometric Analysis.
Perspectives of People with Multiple Sclerosis About Helminth Immunotherapy.
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study.
Update on Pediatric Optic Neuritis.
Effects of Treating an Overactive Urinary Bladder in Patients with Multiple Sclerosis.
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
Progressive multifocal leukoencephalopathy after CAR T therapy.
Deficit-specific Training in Spinal Disorders
Natural killer cells in multiple sclerosis: a review.
The effect of aquatic physical therapy on patients with multiple sclerosis: A systematic review and meta-analysis.
Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer.
Diseases of the Brain, Head and Neck, Spine 2020–2023: Diagnostic Imaging
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.
StatPearls
Transcutaneous Electrical Spinal Cord Neuromodulator (TESCoN) Improves Symptoms of Overactive Bladder.
N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study.
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.
Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients.
Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial.
Identification of key genes associated with multiple sclerosis based on gene expression data from peripheral blood mononuclear cells.
Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases.
Psychological factors associated with self-management in multiple sclerosis.
Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.
Possible determinants of long-term adherence to physical activity in multiple sclerosis-theory-based development of a comprehensive questionnaire and results from a German survey study.
Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports.
Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes.
Minocycline in MS: Confirmation of Benefit
Association of Multiple Sclerosis Phenotypes with Single Nucleotide Polymorphisms of IL7R, LAG3, and CD40 Genes in a Jordanian Population: A Genotype-Phenotype Study.
Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
Copeptin – a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases.
Progressive Multifocal Leukoencephalopathy associated to treatment with natalizumab in Mexican patient Multiple Sclerosis. Case report, analysis and update.
[Diagnostik Lumbar Puncture – Step by Step].
Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.
Location of first attack predicts the site of subsequent relapses in multiple sclerosis.
Psychometric properties of an Arabic translation of the modified fatigue impact scale in patients with multiple sclerosis.
Trends in FDA drug approvals over last 2 decades: An observational study.
Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)
Streptococcus thermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice.
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis.
Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia.
Transcutaneous Direct Current Stimulation of the Spinal Cord for Treatment of Spasticity in Multiple Sclerosis
When is a Ketogenic Diet Ketogenic? Comment on “Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients, Nutrients 2019, 11, 1156”.
Reply to “When Is a Ketogenic Diet Ketogenic? Comment on Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients 2019, 11, 1156”.
Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis.
MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles.
Multiple sclerosis and intracellular cobalamin defect (MMACHC/PRDX1) comorbidity in a young male.
[Surgical decompression of the peroneal nerve at the level of the fibular head].
Remyelination in multiple sclerosis: from concept to clinical trials.
Epstein-Barr virus and its association with disease – a review of relevance to general practice.
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis.
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
Treatment of metastasized melanoma with combined checkpoint inhibition in a patient with highly active multiple sclerosis.
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.
NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS.
The influence of age at disease onset on future relapses and disability progression in multiple sclerosis patients on immunomodulatory treatment.
Noninvasive spinal neuromodulation to map and augment lower urinary tract function in rhesus macaques.
Case 4: wounds associated with chronic progressive multiple sclerosis.
Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis – a community-based randomized controlled trial.
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity.
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series.
Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis.
Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis.
Early astragaloside IV administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells.
Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation.
MRI features associated with rapid disease activity in clinically isolated syndrome patients at high risk for multiple sclerosis.
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
Benefits of curcumin in brain disorders.
Multiple Sclerosis: Clinical Updates in Women’s Health Care Primary and Preventive Care Review.
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.
Alemtuzumab-related eosinophilic central nervous system vasculitis.
Real-state of autophagy signaling pathway in neurodegenerative disease; focus on multiple sclerosis.
Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity.
Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis.
Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults.
Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study.
Co-occurrence of multiple sclerosis and myasthenia gravis: A case report and review of immunological theories.
Descriptive analysis of free-text comments on healthcare priorities and experiences in a national sample of people with multiple sclerosis.
Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.
Epigenetic aspects of multiple sclerosis and future therapeutic options.
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis.
Elevated D-dimer as an immediate response to alemtuzumab treatment.
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy.
Matching-adjusted comparisons demonstrate better clinical outcomes in patients with relapsing multiple sclerosis treated with peginterferon beta-1a than with teriflunomide.
Acute Intermittent Hypoxia in Persons With Multiple Sclerosis
MR-Guided Focused Ultrasound (MRgFUS) for the Management of Tremor in Patients With Multiple Sclerosis
BRCA1/BRCA2-containing complex subunit 3 controls oligodendrocyte differentiation by dynamically regulating lysine 63-linked ubiquitination.
New insights into the novel anti-inflammatory mode of action of glucocorticoids.
Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.
Transcutaneous Electrical Nerve Stimulation in Relieving Neuropathic Pain: Basic Mechanisms and Clinical Applications.
Effects of Ten-Weeks Resistance Training on Neuromuscular Performance and Mobility in Persons With Multiple Sclerosis

Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders
RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif.
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
[Pathological and protective effects of tumor necrosis factor-alpha in multiple sclerosis].
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety].
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).
Therapeutic effects of Tetanus neurotoxin in spinal cord injury: a case series on four dogs.
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus.
Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate: A Global Delphi Approach.
Contraception in autoimmune diseases.
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
Staphylococcal enterotoxin B increased severity of experimental model of multiple sclerosis.
Immunological consequences of “immune reconstitution therapy” in multiple sclerosis: A systematic review.
Reward presentation reduces on-task fatigue in traumatic brain injury.
Venous thromboembolism in multiple sclerosis: a report of two cases with pulmonary embolism on dimethyl fumarate and available data from adverse event reporting systems. Time to include disease modifying drugs in the equation?
Management of diabetes and hypertension in people with multiple sclerosis.
Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis.
A tumefactive demyelinating lesion in a person with MS after five years of fingolimod.
The Effects of Carbenoxolone against Experimental Autoimmune Encephalomyelitis in a Mouse Model.
Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue.
Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population.
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options.
Endocannabinoid receptors in the CNS: potential drug targets for the prevention and treatment of neurologic and psychiatric disorders.
Blinded sample size reestimation in event-driven clinical trials: Methods and an application in multiple sclerosis.
Endogenous opioid peptides and brain development: Endomorphin-1 and Nociceptin play a sex-specific role in the control of oligodendrocyte maturation and brain myelination.
The neuropsychological aspects of performance-based Internet navigation skills: A brief review of an emerging literature.
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland.
Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review.
Advances in oral immunomodulating therapies in relapsing multiple sclerosis.
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials.
Frontal brain activity and cognitive processing speed in multiple sclerosis: An exploration of EEG neurofeedback training.
Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.
Environmental risk factors for multiple sclerosis in Japanese people.
Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.
Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art.
Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review.
Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells.
Spinal parenchymal occupation by neural stem cells after subpial delivery in adult immunodeficient rats.
Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination.
Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.
Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats.
Efficacy of the Spanish modified Story Memory Technique in Mexicans with multiple sclerosis: A pilot randomized controlled trial.
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial.
Evaluation of apamin effects on myelination process in C57BL/6 mice model of multiple sclerosis.
Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients.
Four novel mutations in the mitochondrial ND4 gene of complex I in patients with multiple sclerosis.
In Clinic Physical Activity in Persons With Multiple Sclerosis
Unraveling the T-B tangle in anti-CD20 multiple sclerosis therapy.
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.
FTY720 (Fingolimod) Ameliorates Brain Injury Through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment.
Emerging Connections of S1P-Metabolizing Enzymes with Host Defense and Immunity During Virus Infections.
Effects of Treatment with the Hypomethylating Agent 5-aza-2′-deoxycytidine in Murine Type II Collagen-Induced Arthritis.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
Comparison of Vigorous Versus Low Intensity Cool Room Treadmill Training in People With Multiple Sclerosis
Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period?
Cognitive performance and cognitive workload in multiple sclerosis: Two different constructs of cognitive functioning?
Minocycline for Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: A Review of Clinical Effectiveness and Guidelines
Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [commentary].
Idiopathic Thrombocytopenic Purpura: A Rare Syndrome with Alemtuzumab, Review of Monitoring Protocol.
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
Immunoglobulin G index as a biomarker of relapse response to corticosteroids during early stages of multiple sclerosis.
Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE).
Health locus of control and mental health in patients with multiple sclerosis: Mediating effect of coping strategies.
Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Cognitive-motor Interference in Persons With MS: Dual Task Assessment and Training – A Multi-center Study
IL-10-producing regulatory B cells and plasmocytes: Molecular mechanisms and disease relevance.
Beyond the annualized relapse rate: Assessment of cognitive outcome after treatment in paediatric multiple sclerosis.
Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.
Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective U.S. claims study.
Intrathecal Baclofen Dosage for Long-Term Treatment of Patients With Spasticity Due to Traumatic Spinal Cord Injuries or Multiple Sclerosis.
Propranolol diminished severity of rat EAE by enhancing immunoregulatory/protective properties of spinal cord microglia.
Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells.
Dietary phytol reduces clinical symptoms in experimental autoimmune encephalomyelitis (EAE) at least partially by modulating NOX2 expression.
Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis.
Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs.
Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model.
Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis.
Non-Immersive Virtual Reality for Rehabilitation of the Older People: A Systematic Review into Efficacy and Effectiveness.
Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis.
Fingolimod Immune Effects Beyond Its Sequestration Ability.
Curcumin prevents experimental autoimmune encephalomyelitis by inhibiting proliferation and effector CD4+ T cell activation.
Is the walk ratio a window to the cerebellum in multiple sclerosis? A structural MRI study.
Arts & Health Education to Improve Health, Resilience, and Well-Being
Oxidized Lipids in Persistent Pain States.
The relationship between corticospinal tract integrity and lower-extremity strength is attenuated when controlling for age and sex in multiple sclerosis.
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis.
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Pill or needle? Determinants of the preference for long-acting injection over oral treatment in people facing chronic illness.
Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy.
Biologic therapy in the idiopathic inflammatory myopathies.
Flare of hepatitis B virus after fingolimod treatment for relapsing and remitting multiple sclerosis.
Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis.
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders.
Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

Response to commentary of Shirani and Okuda regarding “Unilateral arm rehabilitation for persons with multiple sclerosis using serious games in a virtual reality approach: Bilateral treatment effect?”
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity.
CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis.
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment.
Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation.
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations.
Ethyl pyruvate enhances spontaneous remyelination by targeting microglia phagocytosis.
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.
FMT for MS Patients
Fampridine-SR and Optic Neuritis Recovery
Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice.
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
Physical activity participation according to the pyramidal, sensory, and cerebellar functional systems in multiple sclerosis.
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients.
Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis.
Small Molecule Antagonists of NAADP-Induced Ca2+ Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease.
Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
[Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex].
Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases.
2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis.
Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial.
Artemisia dracunculus L. modulates the immune system in a multiple sclerosis mouse model.
Secukinumab for patients with plaque psoriasis affected by multiple sclerosis. A mini-review with a representative case report.
Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.
Clinical and radiological findings of facial paralysis in multiple sclerosis.
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines.
Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis.
HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis.
Stem cell therapy for neurological disorders.
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a.
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.
Natalizumab: Perspectives from the Bench to Bedside.
Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
Functional and self-care capacity of people with multiple sclerosis.
Elongated Flexuous Plant Virus-Derived Nanoparticles Functionalized for Autoantibody Detection.
Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS): Rationale and Methodology.
Management of antiphospholipid syndrome.
Retraining Reflexes: Clinical Translation of Spinal Reflex Operant Conditioning.
Walk With Me: a Mobile Application to Improve Walking in Persons With MS
Underlying Causes and Related Factors, and Rehabilitation Approaches
Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.
Italian Consensus on treatment of spasticity in multiple sclerosis.
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis.
The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker.
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis.
Retinal Degeneration After First-Ever Optic Neuritis Helps Differentiate Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.
Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells.
Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).
Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre.
Advancing Understanding of Transportation Options
Gaze Stability, Dynamic Balance and Participation Deficits in People with Multiple Sclerosis at Fall-Risk.
Introduction to Purinergic Signaling.
Immunomodulatory receptors are differentially expressed in B and T cell subsets relevant to autoimmune disease
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Brain activation patterns associated with paragraph learning in persons with multiple sclerosis: The MEMREHAB trial.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Multiple cardiac rhabdomyomas in tuberous sclerosis complex: case report and review of the literature.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Adherence to Treatment in Patients with Chronic Diseases: From Alertness to Persistence.
Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine.
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up.
[Multiple Sclerosis: Neurorehabilitation and Symptomatic Treatment].
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data.
Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
Using an interactive virtual environment to integrate a digital Action Research Arm Test, motor imagery and action observation to assess and improve upper limb motor function in patients with neuromuscular impairments: a usability and feasibility study protocol.
Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients.
Altered motor plasticity in an acute relapse of multiple sclerosis.
Supra-Spinal Modulation Of Walking In Healthy Individuals And Persons With Multiple Sclerosis: A fNIRS Mobile Imaging Study.
Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions.
Palliative care interventions for people with multiple sclerosis.
TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.
Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis.
Phloroglucinol derivative compound 21 attenuates cuprizone-induced multiple sclerosis mice through promoting remyelination and inhibiting neuroinflammation.
Setmelanotide, a Novel, Selective Melanocortin Receptor-4 Agonist Exerts Anti-inflammatory Actions in Astrocytes and Promotes an Anti-inflammatory Macrophage Phenotype.
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression.
Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab.
Joint application of magnetic resonance imaging and biochemical biomarkers in diagnosis of multiple sclerosis.
Reliability and minimal detectable change in the gait assessment and intervention tool in patients with multiple sclerosis.
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
Fasting as a Therapy in Neurological Disease.
Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: qualitative interview study of patient perspectives.
Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?
JC virus antibodies in Portuguese multiple sclerosis patients: JUSTIFY study results.
[The pegylated form of interferon beta in the treatment of multiple sclerosis].
[The role of glutamate in the pathogenesis of multiple sclerosis].
Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases.

[Tardue scales in the diagnostic of spasticity].
Supervised Perturbation Training Results in Changes in Balance and Falling in Patients With Multiple Sclerosis
The Role of Inflammation in Neurological Disorders.
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
e-Health and multiple sclerosis: An update.
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study.
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.
Participation in social/lifestyle activities in people with multiple sclerosis: Changes across 10 years and predictors of sustained participation.
Altered hypothalamic metabolism in early multiple sclerosis – MR spectroscopy study.
Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study.
Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis
Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis
Stroke and seizure continue to be the major brunt of in patient neurology care. An observation from teaching hospital.
Outcomes of patients with multiple sclerosis at a neurorehabilitation unit in Saudi Arabia.
Neurosteroidogenesis and progesterone anti-inflammatory/neuroprotective effects.
Quality of life assessment among multiple sclerosis patients in Saudi Arabia.
Multiple sclerosis and myasthenia gravis following severe weight loss.
Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMS.
[Multiple sclerosis in central Hungary: experiences and future possibilities of developing a local database].
Informing the design of exercise programs for persons with multiple sclerosis who use wheelchairs: a qualitative inquiry of perceived components.
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm.
Focused ultrasound thalamotomy for multiple sclerosis-associated tremor.
Focal Thickness Reduction of the Ganglion Cell-Inner Plexiform Layer Best Discriminates Prior Optic Neuritis in Patients With Multiple Sclerosis.
StatPearls
Quantification characteristics of digital spiral analysis for understanding the relationship among tremor and clinical measures in persons with multiple sclerosis.
More than meets the eye: Point-of-care ultrasound diagnosis of acute optic neuritis in the emergency department.
Prospective study of clinical, neurophysiological and urodynamic findings in multiple sclerosis patients undergoing percutaneous transluminal venous angioplasty.
[Nutritional approach in systemic sclerosis: about a case].
Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases.
Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells.
Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.
Letter to the Editor. Multiple sclerosis-related tremor and stereotactic radiosurgery.
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis.
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.
Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation.
Exercise on Multiple Sclerosis Patients
Video Game-based Physical Activity Training in People With Multiple Sclerosis During Relapse Treatment
Skin warts during fingolimod treatment in patients with multiple sclerosis.
Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis.
Demystifying spasticity in primary care.
Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies.
Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis.
The cost of a catheter: An environmental perspective on single use clean intermittent catheterization.
Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: a Comparative Study of Indication, Efficacy and Safety.
2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy.
Siponimod in the treatment of multiple sclerosis.
[Neuromyelitis optica].
[Demyelinizing diseases in children. Acute disseminated encephalomyelitis and multiple sclerosis].
Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets.
Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia: A population-based analysis.
[The burden of informal caregivers of multiple sclerosis patients: a pilot study].
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia.
Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Repeated Attacks of Dizziness Caused by a Rare Mitochondrial Encephalomyopathy.
Herpes Simplex Virus 1 induces brain inflammation and multifocal demyelination in cotton rats Sigmodon hispidus.
Early IFNγ-Mediated and Late Perforin-Mediated Suppression of Pathogenic CD4 T Cell Responses Are Both Required for Inhibition of Demyelinating Disease by CNS-Specific Autoregulatory CD8 T Cells.
Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?
Progressive multiple sclerosis: latest therapeutic developments and future directions.
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results.
Cannabis-based product use in a multiple sclerosis cohort.
Periventricular Hyperintensities Mimicking Multiple Sclerosis.
Assessing Barriers to Adherence with the Use of Dimethyl Fumarate in Multiple Sclerosis.
Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
To Investigate the Effect of Aerobic Exercise on Neurophysiological Values and Functionality in Individuals With Multiple Sclerosis.
A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children With Multiple Sclerosis
Validation of a Shared Decision-Making Tool for Multiple Sclerosis
Imaging Pediatric Multiple Sclerosis-Challenges and Recent Advances.
Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’.
Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic Review.
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.
Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
Rehabilitation of neuromyelitis optica: Two CARE-compliant case reports.
An Eight-week RCT of Home-based Pilates for Symptoms of Anxiety, Depression, and Fatigue Among People With MS
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
Landscape of MS patient cohorts and registries: Recommendations for maximizing impact.
Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis.
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
Influence of diet on axonal damage in the EAE mouse model of multiple sclerosis.
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.
Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Pioglitazone is superior to quetiapine, clozapine and tamoxifen at alleviating experimental autoimmune encephalomyelitis in mice.
Does pregnancy affect women with multiple sclerosis? A prospective study in Western China.
Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis.
4-Aminopyridine ameliorates relapsing remitting experimental autoimmune encephalomyelitis in SJL/J mice.
Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis.
Optic nerve involvement in experimental autoimmune encephalomyelitis to homologous spinal cord homogenate immunization in the dark agouti rat.
Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis.
1,25-Dihydroxyvitamin D3 increases the methionine cycle, CD4+ T cell DNA methylation and Helios+Foxp3+ T regulatory cells to reverse autoimmune neurodegenerative disease.
Extended Freeze-Dried BCG Instructed pDCs Induce Suppressive Tregs and Dampen EAE.
Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study.
Microglia and astroglia proliferation within the normal appearing white matter in histologically active and inactive multiple sclerosis.
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
Towards a Comprehensive Etiopathogenetic and Pathophysiological Theory of Multiple Sclerosis.

Ac-SDKP ameliorates the progression of experimental autoimmune encephalomyelitis via inhibition of ER stress and oxidative stress in the hippocampus of C57BL/6 mice.
CD3-CD56+ NK cells display an inflammatory profile in RR-MS patients.
Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P1 receptor agonists.
A Personalised Radiosurgery Procedure for People With Trigeminal Neuralgia to Improve Pain, Quality of Life and Reduce Complications
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review.
Transcranial direct current stimulation (tDCS) for the treatment of a Multiple Sclerosis symptom cluster.
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients.
A challenging case of concurrent multiple sclerosis and anaplastic astrocytoma.
VIGIP-SEP2: Evaluation of the Impact of the Training of Patients by a Nurse on the Adverse Drug Reaction Reporting by RRMS Patient Via a Mobile Application: Randomized Real-life Study
Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®
Novel inhibitors of leukocyte transendothelial migration.
Synthetic PreImplantation Factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice.
Gut Microbiota in Neurological Disorders.
Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review.
Self-efficacy and walking performance across the lifespan among adults with multiple sclerosis.
Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study.
Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis.
The Utilization of Yoga as a Therapeutic Tool to Promote Physical Activity Behavior Change and Improved Postural Control in Individuals With Multiple Sclerosis
High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.
IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2Rα therapies.
Electrical stimulation in the treatment of bladder dysfunction: technology update.
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.
Educational and Exercise Intervention to Prevent Falls and Improve Participation in Subjects With Neurological Conditions: The NEUROFALL Randomized Controlled Trial.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
The use of brain stimulation in the rehabilitation of walking disability in patients with multiple sclerosis: A randomized double-blind clinical trial study.
Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption.
Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders.
Interhermispheric inhibition predicts anxiety levels in multiple sclerosis: A corticospinal excitability study.
Prolactin and autoimmunity: The hormone as an inflammatory cytokine.
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial.
An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis.
Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis.
The association between gait variability with the energy cost of walking depends on the fall status in people with multiple sclerosis without mobility aids.
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population.
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.
Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis.
Long noncoding RNAs associated with phenotypic severity in multiple sclerosis.
Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait.
Expert opinion: Criteria for second-line treatment failure in patients with multiple sclerosis.
Effect of combined exercise training on serum brain-derived neurotrophic factor, suppressors of cytokine signaling 1 and 3 in patients with multiple sclerosis.
Pulmonary manifestations in tuberous sclerosis complex.
Siponimod (BAF-312) Attenuates Perihemorrhagic Edema And Improves Survival in Experimental Intracerebral Hemorrhage.
Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.
A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple Sclerosis.
Critically appraised paper: Multidisciplinary inpatient rehabilitation for multiple sclerosis may delay declines in health-related quality of life over 6 months [synopsis].
Atypisk optikusnevritt.
A Pilot Study of the Relationship Between Pregnancy and Autoimmune Disease: Exploring the Mother’s Psychological Process.
The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis.
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis.
Immunomodulatory and neuroprotective mechanisms of Huangqi glycoprotein treatment in experimental autoimmune encephalomyelitis.
Stimulator of Interferon Genes Agonists attenuate type I diabetes progression in NOD mice.
Behavioral economic demand for medications and its relation to clinical measures in multiple sclerosis.
Reduced Visual Quality of Life Associated with Migraine is Most Closely Correlated with Symptoms of Dry Eye.
Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis.
Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion?
The Effectiveness of Self-care Program on the Life Quality of Patients with Multiple Sclerosis in 2015.
Listeria monocytogenes-Induced Rhombencephalitis in a Patient With Multiple Sclerosis Treated With Dimethyl Fumarate.
Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran.
The natalizumab wearing-off effect: End of natalizumab cycle; recurrence of MS symptoms.
Multiple sclerosis.
Multiple sclerosis.
Fumaric Acids Do Not Directly Influence Gene Expression of Neuroprotective Factors in Highly Purified Rodent Astrocytes.
Intervention for Employed Women With Multiple Sclerosis: a Randomized Clinical Trial
Time-Based Prospective Memory Is Associated with Functional Performance in Persons with MS.
Hyperstable arousal regulation in multiple sclerosis.
Teriflunomide suppresses T helper cells and dendritic cells to alleviate experimental autoimmune uveitis.
Epilepsy in multiple sclerosis as a network disease.
Abnormalities and erythroblasts in peripheral blood of multiple sclerosis patients treated with natalizumab.
Does evidence support vitamin D treatment for multiple sclerosis?
Rituximab-induced serum sickness in multiple sclerosis patients.
Transcranial magnetic stimulation and bladder function: A systematic review.
Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.
[Autologous haematopoietic stem cell transplantation of patients with multiple sclerosis].
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study.
Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines.
Hypercalcaemia due to Hypervitaminosis D in a Self-Supplementing Multiple Sclerosis Patient: A Case Report
Aerobic Training Effects on Motor and Cognitive Performances in MS: an Exploratory Study With Structural and Functional MRI
Classic Block Design “Pseudo”-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis.
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.
Brain anatomical correlates of fatigue in multiple sclerosis.
Transdermal delivery of 4-aminopyridine accelerates motor functional recovery and improves nerve morphology following sciatic nerve crush injury in mice.
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.
Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.
Comparison of Copaxone® and Synthon’s therapeutically equivalent glatiramer acetate.
Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.
Fingolimod’s Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.
Management of relapsing-remitting multiple sclerosis in Qatar: an expert consensus.
Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
Randomized controlled trial of SystemCHANGE™ weight management intervention in neurological conditions.
Potential for diet to prevent and remediate cognitive deficits in neurological disorders.
[Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation].
Inhibitory B cell co-receptors and autoimmune diseases.
Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate.
The Impact of Cannabinoid Receptor 2 Deficiency on Neutrophil Recruitment and Inflammation.
Clean intermittent self-catheterisation and multiple sclerosis.

Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study.
CNS-resident classical DCs play a critical role in CNS autoimmune disease.
Dimethyl fumarate mitigates optic neuritis.
Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 1.
Translation and Validation of the Turkish Version of Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study.
No evidence of associations among body composition and symptoms in persons with multiple sclerosis.
Effect of arm cycling and task-oriented exercises on fatigue and upper limb performance in multiple sclerosis: a randomized crossover study.
Profound but transient changes in the inflammatory milieu of the blood during autologous hematopoietic stem cell transplantation.
Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatments.
Teriflunomide’s effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis.
TRAIN-BW: Backward Walking Training in Multiple Sclerosis
Effects of A Dual-Task Intervention in Postural Control in Multiple Sclerosis Patients
[Anorectal disorders in patients with multiple sclerosis: Physiopathology, prevalence, impact, and management].
Functional Deimmunization of Interferon Beta-1b by Identifying and Silencing Human T Cells Epitopes.
Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein.
Predictors of people’s perceptions of second hand smoke exposure as a risk factor for multiple sclerosis.
Long-term use of interferon-β in multiple sclerosis increases Vδ1-Vδ2-Vγ9- γδ T cells that are associated with a better outcome.
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod.
Clinical and Radiological Profiles, Treatment, and Outcome of Pediatric Acquired Demyelinating Disorders of Central Nervous System.
Effect of Interferon-Beta Treatment on the Proportion of Th17 Cells and Related Cytokines in Multiple Sclerosis: A Meta-Analysis.
Instrumental Assessment of Stair Ascent in People With Multiple Sclerosis, Stroke, and Parkinson’s Disease: A Wearable-Sensor-Based Approach.
Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study.
MRI features associated with high likelihood of conversion of radiologically isolated syndrome to multiple sclerosis.
Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis.
Feasibility and Effects of Structured Physical Exercise Interventions in Adults with Relapsing-Remitting Multiple Sclerosis: A Pilot Study.
Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.
Detection of a new melanoma in a patient treated with fingolimod.
Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis.
Neurosteroids as regulators of neuroinflammation.
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.
The relationship of dose to nerve volume in predicting pain recurrence after stereotactic radiosurgery in trigeminal neuralgia.
[Chronic diseases in neuromotor rehabilitation medicine.]
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent.
Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.
Nine-year follow up after hematopoietic stem cell transplantation in five multiple sclerosis patients.
Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides.
Effects of Cladribine Tablets on the Pharmacokinetics of Microgynon®
Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report.
Inducible nitric oxide synthase inhibitors: A comprehensive update.
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients.
FTY720P Upregulates the Na+/K+ ATPase in HepG2 Cells by Activating S1PR3 and Inducing PGE2 Release.
Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.
A Retrospective Review of the Outcomes and Utility of Percutaneous Radiofrequency Rhizotomy for Trigeminal Neuralgia Using Anatomic Landmark Guidance in Asleep Patients.
Clinical Course of Multiple Sclerosis.
Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study.
High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial.
Drug exposure and the risk of multiple sclerosis: A systematic review.
Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report.
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation.
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
An equine-assisted therapy intervention to improve pain, range of motion, and quality of life in adults and older adults with arthritis: A randomized controlled trial.
Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathway.
Fingolimod and changes in hematocrit, hemoglobin and red blood cells of patients with multiple sclerosis.
Synaptic alterations and immune response are sexually dimorphic in a non-pertussis toxin model of experimental autoimmune encephalomyelitis.
Constraint-induced movement therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.
Predicting PET-derived demyelination from multimodal MRI using sketcher-refiner adversarial training for multiple sclerosis.
Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD).
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial.
Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.
Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis.
Fatigue and physical functioning in children with multiple sclerosis and acute disseminated encephalomyelitis.
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study.
Medication usage and falls in people with multiple sclerosis.
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis.
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Yes.
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Commentary.
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – No.
Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Genetic detection of Sonic hedgehog (Shh) expression and cellular response in the progression of acute through chronic demyelination and remyelination.
Multiple sclerosis: oral health, behaviours and limitations of daily oral hygiene – a questionnaire study.
Continuous cuprizone intoxication allows active experimental autoimmune encephalomyelitis induction in C57BL/6 mice.
Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial.
Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases.
Non-invasive brain stimulation for fatigue in multiple sclerosis patients: A systematic review and meta-analysis.
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.
The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.
Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis.
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
[Prevalence of Poor Sleep Quality and Sleep Disturbances in Icelanders with Multiple Sclerosis].
The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US.
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod.
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model.
Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation.
Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease.
Docosahexaenoic acid (22:6n-3) Ameliorated the Onset and Severity of Experimental Autoimmune Encephalomyelitis in Mice.
Combating the Spread of Ineffective Medical Procedures: A Lesson Learned From Multiple Sclerosis.
Lifestyle Intervention for Young Adults with MS: A Design Study.
Impact of Multiple Sclerosis Project ECHO (Extension for Community Healthcare Outcomes) on Provider Confidence and Clinical Practice.
[Multiple mononeuropathy associated with systemic sclerosis with vasculitis confirmed by nerve biopsy: a case report].
Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity.

Impact, Frequency, and Severity of Restless Legs Syndrome in Patients with Multiple Sclerosis in Argentina.
Letter to the Editor: Importance of Early Treatment of Multiple Sclerosis Exacerbations.
Relationship Between Anxiety and Cognition in Multiple Sclerosis: Implications for Treatment.
Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Video-based pairwise comparison: enabling the development of automated rating of motor dysfunction in multiple sclerosis.
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
NLRP3 gain-of-function in CD4+ T lymphocytes ameliorates experimental autoimmune encephalomyelitis.
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Stereotactic radiosurgery for medically refractory multiple sclerosis-related tremor.
Intracranial Inoculation Is More Potent Than Intranasal Inoculation for Inducing Optic Neuritis in the Mouse Hepatitis Virus-Induced Model of Multiple Sclerosis.
Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS.
Effects of intestinal nematode treatment on CD11b activation state in an EAE mouse model of multiple sclerosis.
Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy.
Beyond cognitive dysfunction: Relevance of ecological validity of neuropsychological tests in multiple sclerosis.
Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis.
Beyond rehabilitation in MS: Insights from non-invasive brain stimulation.
Beyond current research practice: Methodological considerations in MS rehabilitation research (is designing the perfect rehabilitation trial the Holy Grail or a Gordian knot?).
Beyond supervised therapy: Promoting behavioral changes in people with MS.
A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
Novel Nanosensor Array for Detection of Volatile Biomarkers From Skin in Multiple Sclerosis
Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.
Factors Affecting Adherence with Telerehabilitation in Patients with Multiple Sclerosis.
Comparing costs of illness of multiple sclerosis in three different years: A population-based study.
Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study.
Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis.
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.
Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques.
Treatment with Rituximab in the Acute Phase of Relapsing Remitting Multiple Sclerosis: A Case Report.
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
Cognitive function in multiple sclerosis: A long-term look on the bright side.
Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis
A Review of Women’s Neurology.
Designing Telerehabilitation System for Multipronged Exercise in Patients with Multiple Sclerosis.
Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences.
Psychometric properties of the Persian-version of the Activities-specific Balance Confidence scale and Fall Efficacy Scale-International in Iranian patients with multiple sclerosis.
Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis.
Diagnostics and Treatments of Iron-Related CNS Diseases.
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm: Erratum.
Multiple sclerosis: Extracranial venous angioplasty is ineffective to treat MS.
Comparison of seating, powered characteristics and functions and costs of electrically powered wheelchairs in a general population of users.
Bipedal hopping timed to a metronome to detect impairments in anticipatory motor control in people with mild multiple sclerosis.
[Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]
Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.
Pregnancy rates and outcomes in women with and without MS in the United States.
The spectrum of immune-mediated and inflammatory lesions of the brainstem: Clues to diagnosis.
Chitin Micro Particles Regulate Splenocytes Immune Response in Experimental Autoimmune Encephalomyelitis.
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis.
B cell depletion can be effective in multiple sclerosis but failed in a patient with advanced childhood cerebral X-linked adrenoleukodystrophy.
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis.
The role of sensory processing difficulties, cognitive impairment, and disease severity in predicting functional behavior among patients with multiple sclerosis.
Retinal vasculopathy with cerebral leukoencephalopathy (RVCL): A rare mimic of tumefactive MS.
Responsiveness and meaningful improvement of mobility measures following MS rehabilitation.
Prognostic factors of disability in relapsing remitting multiple sclerosis.
Protective stepping in multiple sclerosis: Impacts of a single session of in-place perturbation practice.
[The use of alemtuzumab after non-selective immunosuppression in a patient with highly active rapidly progressive remitting multiple sclerosis].
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D.
The long-term effects of disease modifying therapies on disability in people living with multiple sclerosis: A systematic review and meta-analysis.
Vigorous Cool Room Treadmill Training
Ultrasonographic evaluation of the diaphragm thickness in patients with multiple sclerosis.
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.
Excessive daytime sleepiness and fatigue in neurological disorders.
When an octopus has MS: Application of neurophysiology and immunology of octopuses for multiple sclerosis.
Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.
Rare case of double migration of thoracic intradural schwannoma.
Vaccination in Multiple Sclerosis: Friend or Foe?
Cytomegalovirus primary infection in a patient with multiple sclerosis treated with alemtuzumab.
Efficacy and safety of siponimod for multiple sclerosis: Protocol for a systematic review and meta-analysis.
German translation, cultural adaption and validation of the unidimensional self-efficacy scale for multiple sclerosis: a study protocol.
Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta-1b injection for multiple sclerosis treatment.
Hyperpolarized 13 C magnetic resonance spectroscopy detects toxin-induced neuroinflammation in mice.
Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.
Update on pediatric optic neuritis.
Women on multiple sclerosis clinical trial steering committees.
A TLR-CXCL1 pathway in DRG neurons induces neutrophil accumulation in the DRG and mechanical allodynia in EAE mice.
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.
Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice.
Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis.
MiR-125a-5p Regulates Vitamin D Receptor Expression in a Mouse Model of Experimental Autoimmune Encephalomyelitis.
Dietary Therapy in Secondary Progressive Multiple Sclerosis: A Case Report.
An update on the safety of treating relapsing-remitting multiple sclerosis.
Developing a fall prevention program: what are the views and opinions of people with multiple sclerosis?
Efficacy of Project BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study
Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial.
StatPearls
Improvement During Inpatient Rehabilitation Among Older Adults With Guillain-Barré Syndrome, Multiple Sclerosis, Parkinson Disease, and Stroke.
Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study.
Personalised profiling to identify clinically relevant changes in tremor due to multiple sclerosis.
Circulating mesenchymal stem cells, stromal derived factor (SDF)-1 and IP-10 levels increased in clinically active multiple sclerosis patients but not in clinically stable patients treated with beta interferon.
Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis.
Rash developing after cessation of Daclizumab for relapsing remitting MS; a case series.
MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.
Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis.
The Effect of Broad-Spectrum Dietary Supplementation on Quality of Life, Symptom Severity, and Functioning in Multiple Sclerosis.
A Revised Motor Activity Log Following Rasch Validation (Rasch-Based MAL-18) and Consensus Methods in Chronic Stroke and Multiple Sclerosis.

Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain – A Case Report.
Optic Neuritis In the Era of Biomarkers.
Cryogel scaffolds for regionally constrained delivery of lysophosphatidylcholine to central nervous system slice cultures: a model of focal demyelination for multiple sclerosis research.
Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice.
Advantages of virtual reality in the rehabilitation of balance and gait: Systematic review.
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Neutralising antibodies to interferon-beta therapy in relapsing multiple sclerosis: a pilot study.
Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis.
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis.
Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders.
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis.
Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS.
Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials.
Opportunities for cannabis in supportive care in cancer.
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis
The tension between early diagnosis and misdiagnosis of multiple sclerosis.
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.
Tackling comorbidity in multiple sclerosis.
Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification.
Gait Variability and Energy Cost of Oveground Walking in Persons With Multiple Sclerosis: A Cross-Sectional Study.
Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis.
Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.
Poststroke emotionalism with dacrystic (Crying) episodes – making a case for risperidone.
Meta-analytic and Scoping Study on Strength Training in People With Multiple Sclerosis.
Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis.
Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology.
Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D3.
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model.
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.
Exercise-induced lactate responses in Multiple Sclerosis: A retrospective analysis.
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy.
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis.
Risk of cancer among Finnish multiple sclerosis patients.
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.
Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis
The clinical spectrum and prognosis of idiopathic acute optic neuritis: A longitudinal study in Southern Finland.
Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?
Butyrate suppresses demyelination and enhances remyelination.
A randomized pragmatic trial of telephone-delivered cognitive behavioral-therapy, modafinil, and combination therapy of both for fatigue in multiple sclerosis: The design of the “COMBO-MS” trial.
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS.
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Construct validity and test-retest reliability of the Swedish version of the Acceptance of Chronic Health Conditions Scale.
Nocebo in Biosimilars and Generics in Neurology: A Systematic Review.
Targeting Phosphodiesterases-Towards a Tailor-Made Approach in Multiple Sclerosis Treatment.
[Genetic Markers for Personalized Therapy of Polygenic Diseases: Pharmacogenetics of Multiple Sclerosis].
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Treating relapsing multiple sclerosis with dimethyl fumarate.
Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication.
Application device for THC:CBD oromucosal spray in the management of resistant spasticity: pre-production testing.
Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.
Chronic myelitis associated with zoster sine herpete: A case report.
Corpus callosotomy for drug-resistant spasms associated with tuberous sclerosis complex.
Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-κB1/p50 in multiple sclerosis.
Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialities.
Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Resective surgery in tuberous Sclerosis complex, from Penfield to 2018: A critical review.
A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab
Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis.
Longitudinal spinal cord atrophy in multiple sclerosis using the generalised boundary shift integral.
Siponimod (Mayzent)–a new drug for multiple sclerosis.
Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
Targeted Diet Modification Reduces Multiple Sclerosis-like Disease in Adult Marmoset Monkeys from an Outbred Colony.
The Bu Shen Yi Sui Formula Promotes Axonal Regeneration via Regulating the Neurotrophic Factor BDNF/TrkB and the Downstream PI3K/Akt Signaling Pathway.
Central Nervous System Opportunistic Infections.
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.
Novel Molecular Leads for the Prevention of Damage and the Promotion of Repair in Neuroimmunological Disease.
The Role of Inflammation in Depression and Fatigue.
Exploring the outcome of multiple sclerosis among Saudi adult patients. A single-centered cross-sectional study at King Abdulaziz Medical City in Riyadh, Saudi Arabia.
Is non-traditional therapy for multiple sclerosis overwhelming in Saudi Arabia.
Paroxysmal dystonia as an initial presentation of multiple sclerosis posing a diagnostic challenge.
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis.
The role of zinc, copper, manganese and iron in neurodegenerative diseases.
Nitration of Drp1 provokes mitophagy activation mediating neuronal injury in experimental autoimmune encephalomyelitis.
The effects of Clinical Pilates training on walking, balance, fall risk, respiratory, and cognitive functions in persons with multiple sclerosis: A randomized controlled trial.
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders.
Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy.
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis.
[Aspects of nutrition for prevention and treatment of chronic neurological diseases].
Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice Via Metabolomics and Lipidomics.
Adaptation to repeated gait-slip perturbations among individuals with multiple sclerosis.
Real-world effectiveness of fingolimod in Polish group of patients with relapsing-remitting multiple sclerosis.
Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
Authorship of phase 3 trials in multiple sclerosis.
The Co-design of Hand Rehabilitation Exercises for Multiple Sclerosis Using Hand Tracking System.
Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis.
Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study.
Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model.
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes.
Calorie Restriction in Multiple Sclerosis
Dimethyl Fumarate Attenuates Oxaliplatin-Induced Peripheral Neuropathy without Affecting the Anti-tumor Activity of Oxaliplatin in Rodents.
2-Carba cyclic phosphatidic acid inhibits lipopolysaccharide-induced prostaglandin E2 production in a human macrophage cell line.
Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis.
Exercise intensity-dependent immunomodulatory effects on encephalomyelitis.
Cuprizone toxicity and Garcinia kola biflavonoid complex activity on hippocampal morphology and neurobehaviour.
Update on Trigeminal Neuralgia.

The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.
Discovery of Evobrutinib: An Oral, Potent and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases.
Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis
Diagnosis and Management of Progressive Multiple Sclerosis.
Metabolic coupling of axons and glial cells: Implications for multiple sclerosis progression.
SUCCESSFUL TREATMENT OF ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM) BY PROMPT USAGE OF IMMUNOGLOBULINS – CASE REPORT AND REVIEW OF THE LITERATURE.
Aligned Expression of IFI16 and STING Genes in RRMS Patients’ Blood.
How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series.
Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases.
Prioritization of Therapeutic Targets of Inflammation Using Proteomics, Bioinformatics, and In Silico Cell-Cell Interactomics.
Prebiotic vs Probiotic in Multiple Sclerosis
Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma – LC-MS/MS method validation and pre-analytical characteristics.
Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease.
Central Nervous System Infections Complicating Immunosuppression and Transplantation.
Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp).
No Evidence of Disease Activity (NEDA) in Multiple Sclerosis – Shifting the Goal Posts.
Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report.
Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report.
Competition and price among brand-name drugs in the same class: A systematic review of the evidence.
Altered transient brain dynamics in multiple sclerosis: Treatment or pathology?
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.
PML in a person with multiple sclerosis: Is teriflunomide the felon?
The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence.
miR-223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system.
Harding’s disease: an important MS mimic.
A retrospective observational study of Rituximab treatment in multiple sclerosis patients in Cyprus.
Comorbidities in multiple sclerosis-a plea for interdisciplinary collaboration to improve the quality of life of MS patients.
Characterizing Rapid Fluctuations of Resting State Functional Connectivity in Demyelinating, Neurodegenerative, and Psychiatric Conditions: From Static to Time-Varying Analysis.
Fingolimod for Irradiation-Induced Neurodegeneration.
Brain Lesion Segmentation Based on Joint Constraints of Low-Rank Representation and Sparse Representation.
Immunological Aspects of Approved MS Therapeutics.
Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses.
Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis.
Neuroinflammation and Myelin Status in Alzheimer’s Disease, Parkinson’s Disease, and Normal Aging Brains: A Small Sample Study.
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Cordycepin (3′-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis.
Melatonin for Sleep in MS
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Decision Making in Multiple Sclerosis Care Under Uncertainty
Systemic TLR2 tolerance enhances central nervous system remyelination.
Unilateral arm rehabilitation for persons with multiple sclerosis using serious games in a virtual reality approach: Bilateral treatment effect?
Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders.
Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities.
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.
Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.
Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis.
Myelin Water Atlas: A Template for Myelin Distribution in the Brain.
Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data.
Real-World Effectiveness and Safety of Fingolimod in Patients With Relapsing Remitting Multiple Sclerosis: A Prospective Analysis in Buenos Aires, Argentina.
Usefulness of histogram-profile analysis in ring-enhancing intracranial lesions.
Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients.
Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis.
A unique case of multiphasic ADEM or what else?
Lee Silverman Voice Treatment Versus Standard Speech Therapy Versus Control in Hypophonia Rehabilitation in MS
Role of the gut microbiota in the development of various neurological diseases.
[Increased disease activity in a case of multiple sclerosis after switching treatment from fingolimod to natalizumab].
Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents.
Multiple sclerosis and sarcoidosis: A case for coexistence.
Advances in the Understanding and Management of Chronic Pain in Multiple Sclerosis: a Comprehensive Review.
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis.
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Acute disseminated encephalomyelitis following varicella-zoster virus infection: Case report of effective treated both in clinical symptom and neuroimaging.
Dimethyl fumarate and monomethyl fumarate attenuate oxidative stress and mitochondrial alterations leading to oxiapoptophagy in 158N murine oligodendrocytes treated with 7β-hydroxycholesterol.
Cerebral Blood Flow and tDCS
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
Upper Limb Telerehabilitation With Virtual Reality in Multiple Sclerosis
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
Intake of tryptophan-enriched whey protein acutely enhances recall of positive loaded words in patients with multiple sclerosis.
Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis.
Effect of dalfampridine on information processing speed impairment in multiple sclerosis.
Combination therapy with interferon beta-1a and sesame oil in multiple sclerosis.
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis.
Multiple sclerosis in resource-limited settings: Research opportunities in an unequal world.
Validation of the Persian version of the dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis.
Challenging neurological presentations of varicella virus infections in Sudan: Clinical features, imaging and recommendations.
Therapeutic adherence and coping strategies in patients with multiple sclerosis: An observational study.
Update on amyotrophic lateral sclerosis genetics.
Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.
Costs of informal nursing care for patients with neurologic disorders: A systematic review.
Plasma levels of soluble NCAM in multiple sclerosis.
Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study.
Supplementary motor area connectivity and dual-task walking variability in multiple sclerosis.
Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders.
Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review.
Monocyte Mobilisation, Microbiota & Mental Illness.
Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients.
Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.
The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis.
Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis.
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing-Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials.
Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
Mode of Action of Aspirin in Experimental Autoimmune Encephalomyelitis.

[Oral health in patients with systemic sclerosis].
Positive effect of ozonotherapy on serum concentration of soluble interleukin-2 receptor and neopterin in patients with systemic sclerosis.
Morphea induced by treatment with Interferon β-1α.
Cost of disease modifying therapies for multiple sclerosis: Is front-loading the answer?
Patients’ preferences and willingness-to-pay for disease-modifying therapies.
Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
Simplified guideline for prescribing medical cannabinoids in primary care.
Cuprizone-induced demyelination in the mouse hippocampus is alleviated by phytoestrogen genistein.
Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.
The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis.
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.
Long-Term Effects of Whole-Body Vibration on Human Gait: A Systematic Review and Meta-Analysis.
Non-multiple-Sclerosis-Related Typical and Atypical White Matter Disorders: Our Experience in the Last 2 Years in Both Children and Adults From a Tertiary Care Center in India.
Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects.
Occupational performance of individuals with Multiple Sclerosis based on disability level in Iran.
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.
Energy Conservation Management for People With Multiple Sclerosis-Related Fatigue: Who Benefits?
Predictors of Participation and Autonomy in People With Multiple Sclerosis.
A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.
Dendropanax morbiferus leaf extract facilitates oligodendrocyte development.
Investigating the combined effect of pelvic floor muscle exercise and mindfulness on sexual function in women with multiple sclerosis: a randomized controlled trial.
Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study.
Beneficial Effects of Fingolimod in Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Potential.
Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
Treatment with 6-Gingerol Regulates Dendritic Cell Activity and Ameliorates the Severity of Experimental Autoimmune Encephalomyelitis.
Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Is Ustekinumab the best treatment option in patients with Crohn’s disease and coexistent multiple sclerosis?
Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain.
Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.
Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers
An intervention to improve balance in persons with multiple sclerosis.
Is the triple stimulation technique a better quantification tool of motor dysfunction than motor evoked potentials in multiple sclerosis?
Identification of 14-dehydroergosterol as a novel anti-inflammatory compound inducing tolerogenic dendritic cells.
Monoclonal Antibodies for Multiple Sclerosis: An Update.
Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study.
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
Effect of vitamin D replacement on depression in multiple sclerosis patients.
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus?
Management of dysphagia in multiple sclerosis: current best practice.
Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials.
Effectiveness of Vitamin D Supplementation in the Management of Multiple Sclerosis: A Systematic Review.
Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of “too much too soon”.
Calculating potential error in sodium MRI with respect to the analysis of small objects.
The Radiologically Isolated Syndrome: An Opportunity to Prevent Multiple Sclerosis in Children.
Caregiver burden and family functioning in different neurological diseases.
Physical activity and walking performance across the lifespan among adults with multiple sclerosis.
High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.
Multiple Sclerosis and psychosis: A case report.
Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures.
High-dimensional detection of imaging response to treatment in multiple sclerosis.
Environmental correlates of health-promoting leisure physical activity in persons with multiple sclerosis using a social cognitive perspective embedded within social ecological model.
Spinal cord involvement by atrophy and associations with disability are different between MS and NMOSD.
Radiologically isolated syndrome is antiquated amidst evolving McDonald criteria for multiple sclerosis.
A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis.
A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal.
Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in Children.
The Novel Use of Treadmill Plus Music in MS Patients Gate Rehabilitation
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
Harnessing real-world data to inform treatment decisions in multiple sclerosis.
Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients.
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
Exploring the role of music therapy in multiple sclerosis: brief updates from research to clinical practice.
Impact of high-intensity concurrent training on cardiovascular risk factors in persons with multiple sclerosis – pilot study.
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis.
Multiple Sclerosis: Eyes on the Future.
Multiple Sclerosis: B Cells Take Center Stage.
Robust regional cerebral blood flow perfusion deficits in relapsing-remitting multiple sclerosis patients with executive function impairment.
Cognitive functions and social cognition in multiple sclerosis: An overview.
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany].
Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.
Stress management interventions for multiple sclerosis: A meta-analysis of randomized controlled trials.
Demyelination-REMYELINATION of the Rat Caudal Cerebellar Peduncle Evaluated with Magnetic Resonance Imaging.
Cortical excitability changes: A mirror to the natural history of multiple sclerosis?
Pearls & Oy-sters: CNS lymphoma in a patient with relapsing-remitting multiple sclerosis treated with interferon.
Multimodal Molecular Imaging Demonstrates Myeloperoxidase Regulation of Matrix Metalloproteinase Activity in Neuroinflammation.
The astrocyte transcriptome in EAE optic neuritis shows complement activation and reveals a sex difference in astrocytic C3 expression.
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature.
MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients.
The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
TERC promotes cellular inflammatory response independent of telomerase.
tDCS and Glucose Uptake in Leg Muscles
Probenecid arrests the progression of pronounced clinical symptoms in a mouse model of multiple sclerosis.
Drug Treatment of Clinically Isolated Syndrome.
Knowledge, attitudes, beliefs and practices of Occupational Physicians towards seasonal influenza vaccination: a cross-sectional study from North-Eastern Italy.
Changing Physical Activity Behavior in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Dynamic Balance Is Related to Physiological Impairments in Persons With Multiple Sclerosis.
Characterizing Microstructural Tissue Properties in Multiple Sclerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design.
Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab.
Isotype-Switched Autoantibodies Are Necessary To Facilitate Central Nervous System Autoimmune Disease in Aicda-/- and Ung-/- Mice.
ADSTEP: Preliminary Investigation of a Multicomponent Walking Aid Program in People With Multiple Sclerosis.
Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.
Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis.
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4+ and CD8+ T Cells.
Nutrient Composition Comparison between the Low Saturated Fat Swank Diet for Multiple Sclerosis and Healthy U.S.-Style Eating Pattern.
Impact of sex hormones on immune function and multiple sclerosis development.
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

The “Managing Fatigue” programme for people with multiple sclerosis – acceptance and feasibility with Swedish occupational therapists.
Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination.
Imaging Mass Cytometry and Single-Cell Genomics Reveal Differential Depletion and Repletion of B-Cell Populations Following Ofatumumab Treatment in Cynomolgus Monkeys.
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.
A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.
Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up.
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis.
[Intermittent theta-burst transcranial magnetic stimulation for the treatment of spasticity in patients with recurring multiple sclerosis: the results of a double-blind randomised clinical trial].
Safety and Efficacy of Fecal Microbiota Transplantation
Pilates Training in Multiple Sclerosis
Three-week inpatient energy management education (IEME) for persons with multiple sclerosis-related fatigue: Feasibility of a randomized clinical trial.
Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.
Impact of Nonrandomized Dropout on Treatment Switching Adjustment in the Relapsing-Remitting Multiple Sclerosis CLARITY Trial and the CLARITY Extension Study.
Frequently asked questions on seven rare adverse events following immunization.
Characteristics and correlates of coping with multiple sclerosis: a systematic review.
The interpretation of physical activity, exercise, and sedentary behaviours by persons with multiple sclerosis.
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation.
miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.
Therapies for multiple sclerosis targeting B cells.
Protein glycation: An old villain is shedding secrets.
A Pilot Study to Assess At-Home Speed of Processing Training for Individuals with Multiple Sclerosis.
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression.
Pulmonary embolism during the third cycle of alemtuzumab in a patient with relapsing multiple sclerosis.
Modulating proteoglycan receptor PTPσ using intracellular sigma peptide improves remyelination and functional recovery in mice with demyelinated optic chiasm.
A Wheelchair Propulsion Training Program
Health Behaviors, Clinically Isolated Syndrome and Multiple Sclerosis Study
Effects of a Circuit Training on Balance in Persons With Multiple Sclerosis
Multiple sclerosis in Finland 2018- data from the national register.
A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer acetate in relapsing-remitting multiple sclerosis patients.
Multiple sclerosis in 2016: Immune-directed therapies in MS – efficacy and limitations.
Metabolic encephalopathy secondary to diabetic ketoacidosis: a case report.
Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.
Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis.
People with multiple sclerosis report cognitive rehabilitation is effective in increasing strategy use and quality of life but they recommend more caregiver involvement and personal feedback to enhance outcomes.
Gait pattern changes after six-minute walk test in persons with multiple sclerosis.
Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis.
Activity-Guided Design of HDAC11-Specific Inhibitors.
Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.
Serum-based differentiation between multiple sclerosis and amyotrophic lateral sclerosis by Random Forest classification of FTIR spectra.
Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort.
Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care.
Soluble Antigen Arrays Displaying Mimotopes Direct the Response of Diabetogenic T Cells.
The effect of cycling using active-passive trainers on spasticity, cardiovascular fitness, function and quality of life in people with moderate to severe Multiple Sclerosis (MS); a feasibility study.
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
Corrigendum to “Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-Reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study” [Clinical Therapeutics 40 (12) (2018) 2077-2087].
Intensity-dependent clinical effects of an individualized technology-supported task-oriented upper limb training program in Multiple Sclerosis: A pilot randomized controlled trial.
Effects of downslope walking on Soleus H-reflexes and walking function in individuals with multiple sclerosis: A preliminary study.
Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
B cell treatments for multiple sclerosis.
Failure of alemtuzumab therapy to control MOG encephalomyelitis.
Letter re: High hypothetical interest in physician-assisted death in multiple sclerosis.
Letter re: High hypothetical interest in physician-assisted death in multiple sclerosis and Physician-assisted death in chronic neurologic diseases.
Author response: High hypothetical interest in physician-assisted death in multiple sclerosis.
Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.
Acute myocardial infarction associated with initial alemtuzumab infusion cycle in relapsing-remitting multiple sclerosis.
Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy.
Ultrasound-Assisted Diagnosis of Optic Neuritis in the Emergency Department: A Case Report.
Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study.
Multiple sclerosis and Fabry disease – diagnostic “mixup”.
Effects of a Weight Based Training Program on MS Patients
Open-Label Placebos to Treat Fatigue in Multiple Sclerosis
Disrupted CXCR2 signaling in oligodendroglia lineage cells enhances myelin repair in a viral model of multiple sclerosis.
Using biomarkers to predict clinical outcomes in multiple sclerosis.
Roles of circular RNAs in immune regulation and autoimmune diseases.
Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study.
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers.
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments.
Gut microbiota depletion from early adolescence alters adult immunological and neurobehavioral responses in a mouse model of multiple sclerosis.
miR-142-3p as Potential Biomarker of Synaptopathy in MS
Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis
The latest diagnostic criteria and treatment options for neuromyelitis optica.
The ability of clinical balance measures to identify falls risk in multiple sclerosis: a systematic review and meta-analysis.
Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
Comparison of the abbreviated minimal assessment of cognitive function in multiple sclerosis (aMACFIMS) and the brief international cognitive assessment for multiple sclerosis (BICAMS).
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year employment status in multiple sclerosis patients.
Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis.
Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.
Enhanced TLR2 responses in multiple sclerosis.
Effectiveness of robotics in improving upper extremity functions among people with neurological dysfunction: a systematic review.
Neuropathic pain and pain interference are linked to alpha-band slowing and reduced beta-band magnetoencephalography activity within the dynamic pain connectome in patients with multiple sclerosis.
A Review of Available Treatments, Clinical Evidence, and Guidelines for Diagnosis and Treatment of Pediatric Multiple Sclerosis in the United States.
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.
Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.
Healing in the Absence of a Cure.
Web-Based Self-Management Guide for Kidney Transplant Recipients (The Getting on With Your Life With a Transplanted Kidney Study): Protocol for Development and Preliminary Testing.
Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?
Rituximab treatment for multiple sclerosis.
Neuroprotective effects of anthocyanins and its major component cyanidin-3-O-glucoside (C3G) in the central nervous system: An outlined review.
A multi-site, randomized controlled trial of MS INFoRm, a fatigue self-management website for persons with multiple sclerosis: rationale and study protocol.
XO as a Screening Test of Cognitive Impairment in Multiple Sclerosis
Sensory-motor and cardiorespiratory sensory rehabilitation associated with transcranial photobiomodulation in patients with central nervous system injury: Trial protocol for a single-center, randomized, double-blind, and controlled clinical trial.
Impaired local dynamic stability during treadmill walking predicts future falls in patients with multiple sclerosis: A prospective cohort study.
The Cytotoxicity of Epsilon Toxin from Clostridium perfringens on Lymphocytes Is Mediated by MAL Protein Expression.
Rapid-Onset Psychotic Symptoms After Interferon-β-1a Treatment of Multiple Sclerosis.
Pediatric Multiple Sclerosis: A Review.
An industry update in therapeutics: what is the latest news?
Nutritional supplementation of vitamin A and health-related outcomes in patients with multiple sclerosis: A protocol for a systematic review and meta-analysis of randomized clinical trials.